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ABSTRACT 
Cholesterol is an essential component in the membranes of most eukaryotic cells, in which it 
mediates many functions including membrane fluidity, permeability and the formation of 
ordered membrane domains. In this work a fluorescent and a non-fluorescent cholesterol 
analog were characterized as tools to study cholesterol. Next, these analogs were used to 
study two specific cell biological processes that involve cholesterol, i.e. the structure and 
function of ordered membrane domains/rafts and intracellular cholesterol transport.  
The most common method for studying ordered membrane domains is by disrupting them 
by cholesterol depletion. Because cholesterol depletion affects many cellular functions 
besides those mediated by membrane domains, this procedure is highly unspecific. The 
cellular exchange of cholesterol by desmosterol as a tool to study ordered membrane 
domains was characterized. It turned out that the ability of desmosterol to form and 
stabilize membrane domains in vitro was weaker compared to cholesterol. This result was 
reinforced by atomistic scale simulations that indicated that desmosterol has a lower 
ordering effect on phospholipid acyl chains. Three procedures were established for 
exchanging cellular cholesterol by desmosterol. In cells in which desmosterol was the main 
sterol, insulin signaling was attenuated. The results suggest that this was caused by 
desmosterol destabilizing membrane rafts. Contrary to its effect on ordered membrane 
domains  it  was  found  that  replacing  cholesterol  by  desmosterol  does  not  change  cell  
growth/viability, subcellular sterol distribution, Golgi integrity, secretory pathway, 
phospholipid composition and membrane fluidity. Together these results suggest that 
exchanging cellular cholesterol by desmosterol provides a selective tool for perturbing rafts. 
Next, the importance of cholesterol for the structure and function of caveolae was analyzed 
by exchanging the cellular cholesterol by desmosterol. The sterol exchange reduced the 
stability of caveolae as determined by detergent resistance of caveolin-1 and heat 
resistance of caveolin-1 oligomers.  In addition, the sterol exchange led to aberrations in the 
caveolar structure; the morphology of caveolae was altered and there was a larger variation 
in the amount of caveolin-1 molecules per caveola. These results demonstrate that 
cholesterol is important for caveolar stability and structural homogeneity. 
In the second part of this work a fluorescent cholesterol analog was characterized as a tool 
to study cholesterol transport. Tight control of the intracellular cholesterol distribution is 
essential for many cellular processes. An important mechanism by which cells regulate their 
membrane cholesterol content is cholesterol traffic, mostly from the plasma membrane to 
lipid droplets.  The fluorescent sterol probe BODIPY-cholesterol was characterized as a tool 
to analyze cholesterol transport between the plasma membrane, the endoplasmic reticulum 
(ER) and lipid droplets. The behavior of BODIPY-cholesterol was compared to that of natural 
sterols,  using  both  biochemical  and  live-cell  microcopy  assays.  The  results  show  that  the  
transport kinetics of BODIPY-cholesterol between the plasma membrane, the ER and lipid 
droplets is similar to that of unesterified cholesterol. Next, BODIPY-cholesterol was utilized 
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to  analyze  the  importance  of  oxysterol  binding  protein  related  proteins  (ORPs)  for  
cholesterol transport between the plasma membrane, the ER, and lipid droplets in 
mammalian cells. By overexpressing all human ORPs it turned out that especially ORP1S and 
ORP2 enhanced sterol transport from the plasma membrane to lipid droplets. Our results 
suggest that the increased sterol transport takes place between the plasma membrane and 
ER and not between the ER and lipid droplets. Simultaneous knockdown of ORP1S and ORP2 
resulted in a moderate but significant inhibition of sterol traffic from the plasma membrane 
to ER and lipid droplets, suggesting a physiological role for these ORPs in this process. The 
two phenylalanines in an acidic tract (FFAT) motif in ORPs, which mediates interaction with 
vesicle associated membrane protein associated proteins (VAPs) in the ER, was not 
necessary for mediating sterol transport. However, VAP silencing slowed down sterol 
transport, most likely by destabilizing ORPs containing a FFAT motif.  
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INTRODUCTION 
Since its discovery as the main component of gallstones, cholesterol (chol: gall and stereos: 
solid) has remained a molecule with a dubious reputation. By the public, cholesterol is 
probably best known for its involvement in cardiovascular disease, which is the main cause 
of death in the Western world (Lewington et al., 2007). Other cholesterol related disorders 
are Alzheimer’s disease, Niemann-Pick type C (NPC) disease, Familial hypercholesterolemia, 
Tangier disease and several biosynthetic disorders including Desmosterolosis and Smith-
Lemli-Opitz  Syndrome.  It  is  interesting  to  point  out  that  clinical  treatment  of  cholesterol  
related disorders is a profitable enterprise. For example, a cholesterol lowering drug from 
Pfizer called Lipitor (Atorvastatin) is at the moment the best selling drug of all time.  
It is generally less well known that cholesterol is required for the growth and development 
of nearly all animals and eukaryotic cells. Cholesterol has been found to be one of the most 
functionally  diverse  molecules  in  biology.  For  instance,  it  serves  as  a  precursor  for  many  
types of biologically active compounds including, steroid hormones, bile acids, oxysterols 
and vitamin D. However, the most general function of cholesterol among eukaryotic species 
is as a structural component of biological membranes. In cellular membranes, cholesterol is 
a unique constituent that regulates diverse properties including membrane permeability, 
fluidity, and ordered domain formation. 
Because  cholesterol  is  involved  in  many  aspects  of  biology  it  is  not  surprising  that  much  
research has been focused on this small molecule.  Several Nobel prizes have been awarded 
to researchers that studied cholesterol (http://nobelprize.org): Windaus and Wieland for 
solving its molecular structure, Bloch and Lynen for elucidating its biosynthetic pathway, 
and Brown and Goldstein for discovering receptor mediated uptake of cholesterol by cells. 
Despite these key discoveries there are many aspects of the biology of cholesterol which 
remain unclear. For example, it is poorly understood how cholesterol, after uptake by the 
cell,  is  transported  between  different  cellular  organelles.  Another  example  is  the  role  of  
cholesterol in ordered membrane domains. These cholesterol enriched membrane 
assemblies have been suggested to be important for many cellular functions but detailed 
understanding regarding their structure and function is still lacking.  
Relatively little is known about the cellular behavior of cholesterol and other lipids 
compared to the knowledge of proteins and nucleic acids. An important reason for this 
difference is the lack of good tools to study the cellular behavior of lipids.  For example, the 
discovery of green fluorescent protein (GFP) enabled the visualization of proteins in living 
cells and caused a breakthrough in cell-biology (Chalfie et al., 1994). Unfortunately, this 
technology does not apply to lipids and the lack of good fluorescent cholesterol probes has 
hampered biological research on cholesterol. In this work, a fluorescent and a non-
fluorescent cholesterol analog were characterized as tools to study specific cell biological 
aspects of cholesterol, i.e. the structure and function of ordered membrane domains/rafts 
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and intracellular cholesterol transport. Furthermore, this work revealed the importance of 
cholesterol for the stability of caveolae and uncovered roles for ORPs and VAPs in 
cholesterol transport to the ER and lipid droplets in mammalian cells.  
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REVIEW OF THE LITERATURE 
1. Cell biology of cholesterol 
1.1 Cholesterol in biological membranes 
Biological membranes 
Biological membranes are continuous barriers both around and within cells.  They are 
around 5 nm thick and define enclosed compartments; either the cell itself or intracellular 
membrane bound organelles (Figure 1A). The membranes are structurally composed of 
a bilayer of amphiphathic lipids. These lipids contain a polar head group and a hydrophobic 
tail region. Lipid bilayers can form spontaneously upon dispersion of certain lipids in water. 
Lipids reduce the energetically unfavorable interaction between hydrophilic water and their 
hydrophobic tails by aligning their tails towards the center of the bilayer, leaving only their 
polar headgroup to interact with the water molecules (Figure 1B). Due to their hydrophobic 
interior, lipid bilayers are largely impermeable to polar compounds. This enables them to 
function as selective permeability barriers. Other important membrane functions are signal 
transduction, energy transduction, vesicular transport, cell adhesion and cell motility. These 
functions  are  mediated  by  membrane  proteins  which  can  make  up  to  50%  of  the  total  
membrane weight. In 1972 Singer and Nicolson proposed the influential fluid mosaic model 
which stated that lipids and proteins can diffuse freely within the membrane (Singer and 
Nicolson, 1972). Although some aspects of this model are still valid today, it is now known 
that within the fluid membrane there are stable structures including protein complexes, 
cytoskeletal barriers and ordered membrane domains.   
 
 
 
Figure 1. Biological membranes. A) Schematic drawing of a cell indicating the membranes 
that define the cell itself (plasma membrane) the Golgi complex and the ER. For simplicity 
other organelles are omitted. B) Schematic drawing of a lipid bilayer. Circles represent the 
hydrophilic headgroups and the lines represent the hydrophobic tail regions.  
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Membrane lipids  
The major classes of lipids in biological membranes are glycerophospholipids, sphingolipids 
and cholesterol (Figure 2). Glycerophospholipids have a glycerol backbone which is linked by 
oxy-ester bonds to two fatty acids (hydrophobic tail region) and one phosphate or 
a phosphate attached to an alcohol (polar head group). Glycerophospholipids are 
subdivided in types depending on their head group. The major types are 
phosphatidylcholine (PC), phosphatidylserine (PS), phosphatidylethanolamine (PE), 
phosphatidylinositol (PI) and phosphatidylglycerol (PG).  Sphingolipids consist of 
a sphingosine backbone which is attached to a fatty acid and a polar headgroup. The head 
group can either be phospho-choline making up sphingomyelin (the most prominent 
sphingolipid in mammalian membranes) or one or more sugar groups making up the 
glycolipids. The different types of glycerophospho- and sphingolipids are further subdivided 
by the length and degree of unsaturation of their acyl chains. Due to the permutations of 
these structural features the cellular lipidome is theoretically composed of thousands of 
glycerophospholipids and more than 100,000 species of sphingolipids (Yetukuri et al., 2008). 
Although it is not exactly known why there are so many lipids, certain structural features 
have been linked to membrane functions. For instance, lipids with long and saturated acyl 
chains form closely packed membranes.  On the other hand, unsaturated acyl chains are 
more kinked, resulting in weaker van der Waals interactions and more fluid membranes. 
Regulation of membrane thickness and fluidity has been shown to be important for the 
functioning of specific proteins and the membrane barrier function. Another example how 
lipids influence membrane function is illustrated by the concept of hydrophobic matching 
described by the mattress model (Mouritsen and Bloom, 1984); the thickness of 
a membrane with respect to the length of the hydrophobic part of an integral membrane 
protein is important for the lipid-protein interaction and can influence protein function and 
localization.  However, despite the progress made over the last decades, we are only 
beginning to understand how lipids and proteins work in concert to enable biological 
membranes to function. 
 
 
Figure 2. Structures of phosphatidylcholine, sphingomyelin and cholesterol. Blue areas 
indicate the hydrophilic headgroup and the red areas indicated the hydrophobic tail region. 
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Membrane properties of cholesterol 
Cholesterol is a unique lipid that is present in large amounts in the membranes of eukaryotic 
cells. The presence of cholesterol drastically alters the biophysical properties of biological 
membranes. One of the major effects of cholesterol is the promotion of acyl chain order. In 
solution, acyl chains are very flexible structures; since the carbon-carbon single bonds can 
freely  rotate,  acyl  chains  can  bend  in  all  directions.  In  a  membrane,  acyl  chains  are  more  
ordered since they are oriented parallel to each other by the forces that drive bilayer 
formation. Cholesterol within a membrane will position itself between acyl chains, thereby 
causing tighter packing and increased order. This phenomenon is clearly illustrated by the 
cholesterol condensing effect; the average area occupied per molecule in a cholesterol 
phospholipid bilayer is smaller than the sum of areas of the individual components 
(Stockton and Smith, 1976). 
There  are  several  models  that  attempt  to  explain  the  physical  origin  of  the  effect  of  
cholesterol on acyl chain order. The condensed complex model proposes a chemical 
interaction between cholesterol and the acyl chains (McConnell and Radhakrishnan, 2003).  
This interaction forces the acyl chains to straighten and form more ordered and tightly 
packed membranes. The umbrella model, which is related to the more general superlattice 
model (Somerharju et al., 2009), postulates that hydrophobic cholesterol relies on polar 
phospholipid head group coverage to avoid the unfavorable free energy of cholesterol 
contact with water (Huang and Feigenson, 1999).  Because cholesterol now occupies the 
limited space under the phospholipid head groups, the acyl chains are forced together. 
Besides its influence on acyl chain order, cholesterol has various other effects on biophysical 
membrane properties. Cholesterol is known to decrease membrane permeability (Corvera 
et al., 1992). This phenomenon is partly caused by the increase membrane thickness that 
results from the straightening of the acyl chains. Other effects of cholesterol on membranes 
include: thermomechanics, lateral diffusion and binding of solutes. These aspects are 
reviewed in more detail in (Mouritsen and Zuckermann, 2004). Arguably, the most 
distinctive feature of cholesterol in biological membranes is its ability to form ordered 
domains within a liquid bilayer. This unique property of cholesterol will be discussed in more 
detail in the chapter on ordered membrane domains. 
 
1.2 Cellular cholesterol homeostasis 
Because cholesterol is involved in various essential cellular processes and because excess 
free-cholesterol is toxic for cells, regulation of cholesterol levels is of vital importance. This 
regulation is a highly dynamic process since cells continually exchange cholesterol with their 
environment and constantly need cholesterol for cell division. The level of cellular 
cholesterol follows from several processes including cholesterol biosynthesis, uptake, efflux 
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and subcellular storage. In order to coordinate these different processes, cells have evolved 
feedback mechanisms that tightly regulate cholesterol homeostasis.   
  
Biosynthesis   
The biosynthesis of cholesterol is a process consisting of more than 30 enzymatic reactions 
which mostly take place in the ER. The biosynthetic pathway (Figure 3) was elucidated 
mainly by the work of Konrad Bloch (Bloch, 1965), who received the Nobel Prize in medicine 
in 1964 for these efforts. The synthesis starts with acetyl-coenzyme A (acetyl-CoA), which is 
also important for the biosynthesis of fatty acids, amongst other compounds. The first step 
of the synthesis is a condensation reaction of acetyl-CoA and its derivative acetoacetyl-CoA. 
This gives 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA), which is subsequently reduced by an 
enzyme called HMG-CoA reductase (HMGR). This step is rate limiting for cholesterol 
biosynthesis and produces mevalonate. Statins, the pharmacological compounds that lower 
blood cholesterol levels, inhibit this reaction. Mevalonate is further converted into the five-
carbon isopentyl pyrophosphate. This is the basic unit used for the synthesis of all 
isoprenoids, which comprises a large class of molecules that includes menthol and 
cannabinoids. On a side note, because statins inhibit cholesterol biosynthesis at such 
an early step, they not only inhibit the production of cholesterol but also disrupt the 
biosynthesis of all other isoprenoids. In the next step of the biosynthesis, the 5-carbon 
isopentylpyrophosphate condenses with itself in multiple steps to form the 30-carbon 
squalene. Finally squalene is converted to lanosterol, which contains the tetracyclic ring 
structure  that  is  characteristic  for  all  sterols.  After  the  synthesis  of  lanosterol  the  
biosynthesis of cholesterol proceeds with a 19-step process requiring 9 different enzymes 
(Gaylor, 2002). The different steps include the formation, removal and isomerization of 
carbon-carbon double bonds and the removal of methyl groups. Two routes involving the 
same enzymes have been proposed, differing only in the timing of the reduction of the 
carbon-24 double bond. Consequently, cholesterol biosynthesis can proceed with either 
desmosterol (Bloch pathway) or 7-dehydrocholesterol (Kandutsch-Russell pathway) as the 
penultimate precursor of cholesterol. Even though specific cell types prefer one pathway 
over the other, the functional relevance of having two pathways is unknown. 
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Figure 3. Biosynthesis of cholesterol. A) The biosynthesis of squalene from acetyl-CoA. B) 
After the conversion of squalene to lanosterol the biosynthesis of cholesterol can proceed 
either through the Bloch pathway (left) or Kandutsch-Russell pathway (right). Structural 
differences from cholesterol are indicated with red (additional methyl group) and blue dots 
(carbon-carbon bond saturation). 
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Uptake 
Besides biosynthesis, mammalian cells can acquire cholesterol, mostly in its esterified form, 
through uptake of lipoprotein particles from the extracellular environment. This process, 
called forward cholesterol transport, is mainly facilitated by receptor mediated uptake of 
low density lipoprotein (LDL) particles , which has been characterized mostly by the work of 
Brown and Goldstein  (Brown and Goldstein, 1986). After extracellular LDL binds its receptor 
on the cell surface, the complex relocalizes to clathrin coated pits that pinch off from the 
plasma membrane to form an endocytic vesicle. In most familial hypercholesterolemia 
patients this process is disrupted because of mutations in the LDL receptor; this causes 
blood LDL levels to rise which increases the risk of developing cardiovascular disease via the 
atherosclerotic process. After internalization, the complex travels down the endocytic route. 
Meanwhile, the pH within the endosomes decreases, causing LDL to dissociate from its 
receptor.  After this, the receptor can either be transported back to the plasma membrane 
or be targeted for degradation. The cholesterol esters continue to move down the 
endosomal route and are hydrolyzed by a protein called lysosomal acid lipase. Exit of 
cholesterol from the endosomal compartment is mediated by the proteins NPC1 and NPC2. 
It  is  not  entirely  clear  how  the  NPC  proteins  function  but  there  is  evidence  that   soluble  
NPC2 extracts cholesterol from LDL and delivers it to membrane-associated NPC1 that 
incorporates the sterol in the late-endosomal/lysosomal membrane (Kwon et al., 2009). The 
cholesterol is then mixed with the preexisting pool of cellular cholesterol by an unknown 
mechanism. It is worth noting that the internalization of oxidized LDL by macrophages, 
a process important for the development of atherosclerosis, is mediated through a different 
route involving scavenger receptor class A type 1 (SR-AI) and CD36. Furthermore, in 
adrenocortical cells, SR-BI also facilitates uptake of LDL. 
 
Efflux 
Because mammalian cells are unable to break down cholesterol, cells need to secrete 
cholesterol in order to remove it. The cellular secretion of cholesterol by non-hepatic cells is 
often referred to as reverse cholesterol transport and involves the delivery of cholesterol to 
extracellular acceptors. An important acceptor is apolipoprotein A-I (apoA-I) which accepts 
cholesterol through the action of ATP binding cassette transporter A1 (ABCA1), the protein 
defective in Tangier disease. By accumulating lipids, nascent apoA-I containing particles 
mature to spherical high density lipoprotein (HDL) particles. In turn, spherical HDL also acts 
as a cholesterol acceptor.  This type of efflux is mediated by two other ABC–transporters, 
namely ABCG1 and ABCG4  (Wang et al., 2004).  After cholesterol is secreted to the blood in 
HDL  particles  it  can  be  taken  up  by  liver  cells  via  the  function  of  SR-BI  that  facilitates  
selective cholesterol ester uptake from HDL (Acton et al., 1996). In the liver, ABCG5/ABCG8 
are involved in the secretion of cholesterol into the bile (Graf et al., 2003).   
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Cholesterol storage in lipid droplets 
Cells can regulate their subcellular cholesterol levels by deposition of cholesterol in lipid 
droplets. Lipid droplets are cellular organelles that function as storage sites for cholesterol 
and fatty acids, thereby controlling the fat energy reserves of cells. Lipid droplets are also 
essential for regulating the levels of cholesterol and fatty acids that are present in cellular 
membranes. This is done by rapidly enabling cholesterol and fatty acids to be deposited and 
extracted  in  periods  of  excess  and  deficiency  (Martin  and  Parton,  2005).  The  amount  of  
cholesterol stored in lipid droplets varies among cell types and depends on the metabolic 
state of the cell. The lipids are stored in a hydrophobic core which is surrounded by a lipid 
monolayer (Tauchi-Sato et al., 2002). Although lipid droplets contain some free cholesterol, 
generally most cholesterol is stored in esterified form. The enzyme acyl-CoA: cholesterol 
acyltransferase (ACAT), which is present in the ER, catalyzes the esterification of cholesterol 
with a fatty acid. For unknown reasons, adipocytes, which are specialized in cholesterol and 
triacylglyceride storage, store cholesterol in its unesterified form (Schreibman and Dell, 
1975). 
 
Regulation of cholesterol homeostasis 
In order to maintain cholesterol homeostasis, the processes that mediate cholesterol 
biosynthesis, uptake, efflux, and storage, are tightly regulated by several feedback 
mechanisms.  An important transcriptional regulatory mechanism is mediated by sterol 
regulatory element binding protein (SREBP) (Brown and Goldstein, 1997). SREBP is 
a transmembrane protein which is kept in the ER by binding to SREBP cleavage activating 
protein (SCAP). When cholesterol levels are high, the sterol sensing domain in SCAP binds 
cholesterol.  This  causes  SCAP  to  bind  a  protein  called  Insig,  resulting  in  retention  of  the  
entire complex in the ER. When cholesterol levels are low, a conformational change in the 
sterol sensing domain of SCAP abrogates its binding with Insig. As a result the SCAP SREBP 
complex  is  transported  to  the  Golgi  complex  in  COPII  vesicles.  Upon  arrival  in  the  Golgi,  
SREBP gets cleaved releasing a transcription factor that activates the expression of genes 
containing a sterol regulatory element promoter. Many of these genes encode proteins that 
are involved in increasing the cellular cholesterol content, including several enzymes 
involved in cholesterol biosynthesis and the LDL-receptor. Another transcriptional 
regulatory mechanism is mediated by Liver X receptors (LXRs) that sense cellular sterol 
levels by binding to oxidized derivatives of cholesterol. Upon activation, LXRs alter the 
transcription of proteins involved in reverse cholesterol transport (Tontonoz and 
Mangelsdorf,  2003).   Finally,  it  should  be  noted  that  cholesterol  homeostasis  can  also  be  
regulated by post-transcriptional mechanisms. For instance, a rise in cholesterol levels 
causes HMGR to bind Insig, resulting in the degradation of HMGR by the proteasome (Sever 
et al., 2003).  
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1.3 Subcellular distribution of cholesterol  
Cholesterol content of cellular organelles 
It has become clear that cholesterol is unevenly distributed over the membranes of 
different cellular compartments. The ER, where cholesterol is synthesized and its levels are 
regulated, is relatively poor in cholesterol. Yvonne Lange and colleagues analyzed in cell 
homogenates the pool of cholesterol that could be acylated by ACAT, a protein that is 
present in the ER (Lange and Steck, 1997). They found that, depending on growth 
conditions, 0.1-2% of total cellular cholesterol could react with ACAT. The authors suggested 
that this fraction represents the pool of ER cholesterol. The lab of Brown and Goldstein 
isolated ER membranes in a 4-step process and found that cholesterol constitutes 5% of all 
ER lipids (Radhakrishnan et al., 2008). Even though these results are not directly 
comparable,  they  both  agree  on  low  ER  cholesterol  content.  It  seems  likely  that  this  low  
concentration facilitates the SCAP-SREBP complex to sense small changes in cholesterol 
levels. Plasma membrane cholesterol can be analyzed by cholesterol oxidase treatment. 
When added to the cells, this enzyme converts cholesterol in the plasma membrane to 
cholestenone without modifying intracellular cholesterol (Slotte et al., 1989). Cholesterol 
oxidase treatment and subcellular fractionation studies agree that 65-80% of cellular 
cholesterol resides in the plasma membrane and that around 1 out of 3 plasma membrane 
lipids  is  cholesterol  (Liscum  and  Munn,  1999;  Warnock  et  al.,  1993).  In  the  Golgi  the  
cholesterol concentration lies in between that of the ER and plasma membrane (van Meer, 
1998). Furthermore, the concentration appears to increase from the cis to trans direction 
(Coxey et al., 1993). Taken together, it appears that the cholesterol concentration in cellular 
membranes increases along the secretory pathway. Other organelles with high cholesterol 
levels are the endocytic recycling compartment (ERC) (Hao et al., 2002) and internal vesicles 
of multivesicular bodies (Mobius et al., 2003), whereas mitochondria, which are involved in 
steroidogenesis, and lysosomes are generally cholesterol poor (Mobius et al., 2003; Severs, 
1982). 
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Underlying theories for cholesterol gradient 
It is not clear how the concentration gradient of cholesterol is maintained among the 
different membranes. One theory suggests that the amount of cholesterol in a particular 
membrane  is  determined  by  its  affinity  towards  that  membrane  (Lange  and  Steck,  2008;  
Phillips et al., 1987). This affinity is proposed to be dependent on the lipid composition of 
the membrane. Experimental evidence for this theory came from studies analyzing the 
desorption rate of lipids from lipid monolayers. Cholesterol associated in a sphingomyelin 
monolayer  desorbs  more  slowly  than  from  a  PC  monolayer  (Ohvo  and  Slotte,  1996),  and  
furthermore, higher acyl chain unsaturation increases cholesterol desorption (Ramstedt and 
Slotte, 1999).  Indeed the plasma membrane, which is rich in cholesterol, has a high degree 
of fatty acid saturation and is enriched in sphingomyelin. The affinity/stabilization of 
cholesterol in various membranes can be explained by the condensed complex model (see 
1.1 Cholesterol in membranes). The condensed complex model argues that cholesterol forms 
more stable complexes with some lipids compared to others. It has been shown 
experimentally that the van der Waals interactions between cholesterol and acyl chains are 
strongest when the hydrocarbon chains are saturated (Chong et al., 1994). It should be 
noted that alternatively, the cholesterol gradient could be maintained by selective energy 
driven cholesterol transport. However, there is no convincing evidence for this theory. 
 
1.4 Intracellular cholesterol transport 
In order to maintain its subcellular cholesterol distribution, cells have to traffic cholesterol 
from the sites of biosynthesis and internalization towards other compartments. In general, 
lipid transport can be divided into vesicular and non-vesicular mechanisms. Although 
cholesterol has been found in the membranes of both secretory and endocytic vesicles 
(Brugger et al., 2000; Mobius et al., 2003), there is growing evidence that most cholesterol 
traffic between cellular compartments is mediated by non-vesicular transport. This 
transport appears to be facilitated by different families of lipid transfer proteins (LTPs).  
These are soluble proteins with a hydrophobic binding domain capable of trafficking lipids 
between membranes in vitro. There is also evidence for the involvement of membrane 
contact sites. The ER has been shown to be in close contact with most other cellular 
compartments (Loewen et al., 2003). These sites would be ideal for efficient non-vesicular 
lipid  transport  and  some  LTPs  have  been  shown  to  function  at  sites  of  close  membrane  
approximation (Schulz et al., 2009). Finally, it should be noted that although some of the 
players have been revealed, the precise mechanisms of cellular cholesterol transport remain 
unknown.  
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Plasma membrane-ER transport 
An important cholesterol transport route is between the ER, where cholesterol is 
synthesized, and the plasma membrane, where most cholesterol is present. Transport from 
the  ER  to  the  plasma  membrane  can  be  analyzed  by  monitoring  the  arrival  of  newly  
synthesized cholesterol at the plasma membrane. By biochemically isolating plasma 
membranes, Simoni and colleagues found that cholesterol is transported to the plasma 
membrane with a halftime of 10-20 min in an energy dependent manner (DeGrella and 
Simoni, 1982). Yvonne Lange and colleagues detected plasma membrane arrival of 
cholesterol by analyzing its conversion by extracellular cholesterol oxidase. They found 
a transport halftime of around 30 min (Lange et al., 1991).  Brefeldin A treatment, disrupting 
the  Golgi  and  secretory  transport,  has  little  effect  on  the  transport  kinetics  (Heino  et  al.,  
2000; Urbani and Simoni, 1990). In yeast SEC mutants, with conditional defects in proteins 
required for ER-plasma membrane vesicular transport, there is either no block or a partial 
block in cholesterol traffic (Baumann et al., 2005; Schnabl et al., 2005). The reverse route, 
cholesterol  transport  from  the  plasma  membrane  back  to  the  ER,  can  be  analyzed  by  
labeling the plasma membrane with a radioactive-cholesterol isotope and monitoring its 
esterification in the ER. Also this transport is not inhibited in several yeast SEC mutants (Li 
and Prinz, 2004). Furthermore, this transport was shown to be independent of ATP or other 
treatments that affect vesicular transport (Skiba et al., 1996). Taken together these results 
indicate  that  cholesterol  can  move  between  the  plasma  membrane  and  ER  in  a  non-
vesicular fashion. Insights into the mechanisms of non-vesicular transport have emerged 
from research on ORPs, a family of LTPs, which will be discussed in more detail in chapter 4.  
 
Transport to lipid droplets 
The deposition of cholesterol in lipid droplets is essential for maintaining cholesterol 
homeostasis. Most cholesterol moving into lipid droplets comes from the plasma membrane 
(Lange et al., 1993). Using the fluorescent cholesterol probe dehydroergosterol, it was 
shown that cholesterol moves independent of metabolic energy to lipid droplets with 
a  halftime  of   1.5  min   (Wustner  et  al.,  2005).  It  is  not  known  how  cholesterol  and  
cholesterol esters move to lipid droplets. There is evidence that cholesterol targeted to lipid 
droplets moves through the ER. Cholesterol esters are synthesized by ACAT in the ER and 
are either packed directly in lipoprotein particles (only by specialized cell types) or stored in 
lipid droplets. Furthermore, lipid droplets have been visualized in close proximity to the ER 
membrane (Ohsaki et al., 2008). The prevailing theory of lipid droplet biogenesis states that 
they originate from lipid accumulations between the leaflets of the ER membrane (Murphy 
and Vance, 1999; Ohsaki et al., 2009). It is possible that after formation, the lipid monolayer 
that surrounds lipid droplets remains continuous with the ER, ensuring lipid transport 
through lateral diffusion. Alternatively, membrane contact sites between the ER and lipid 
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droplets might be involved. Although the ER is probably the direct source for lipid droplet 
cholesterol, so far no proteins have been implicated in cholesterol transfer between the ER 
and lipid droplets.   
 
Other routes and transporters 
Maxfield  and  colleagues  studied  sterol  transport  from  the  plasma  membrane  to  the  ERC  
using the dehydroergosterol and radiolabeled-cholesterol (Hao et al., 2002). They found 
that traffic was fast (halftime of 2.5 min) and independent of ATP, which suggests that the 
transport is non-vesicular. Surprisingly, dehydroergosterol transport out of the ERC did 
require metabolic energy and was suggested by the authors to be mediated by a vesicular 
pathway.  
Cholesterol has to be transported to the inner mitochondrial membrane in order to be 
converted to pregnenolone, the first step of steroid biosynthesis. Cholesterol movement 
from the outer to the inner mitochondrial membrane has been shown to be mediated by 
steroidogenic acute regulatory protein  (StAR) (Miller, 2007; Rone et al.,  2009). In humans, 
there are at least 14 other StAR related lipid transfer (START) proteins (Alpy and Tomasetto, 
2005). An important member of this family is ceramide transporter (CERT), which has been 
shown to transport ceramide, a precursor of sphingolipid biosynthesis, from the ER to the 
Golgi.  Two  other  members,  STARD3  (MLN64)  and  STARD5,  have  been  shown  to  bind  
cholesterol (Rodriguez-Agudo et al., 2005; Tsujishita and Hurley, 2000). There is evidence 
that these proteins are involved in cholesterol transport to the outer mitochondrial 
membrane  (Charman  et  al.,  2010;  Soccio  et  al.,  2005;  Zhang  et  al.,  2002),  but  a  detailed  
molecular mechanism is lacking.  
Another LTP, sterol carrier protein 2 (SCP-2), promotes the exchange of sterols between 
membranes in vitro and its expression affects sterol trafficking in certain tissue culture 
systems (Baum et al., 1997; Pfeifer et al., 1993; Puglielli et al., 1995; Seedorf et al., 2000). 
However, the apparent lack of specificity for cholesterol and its predominant localization in 
peroxisomes argue against a role for SCP-2 as a sterol transporter (Seedorf et al., 2000). This 
was further corroborated by studies using SCP-2 knockout mice where, rather than a role in 
cholesterol transport, SCP-2 was related to the peroxisomal oxidation of certain fatty acyl-
CoAs  (Seedorf  et  al.,  1998).  Finally,  another  protein  shown  to  be  involved  in  cholesterol  
transport is caveolin, which will be discussed in more detail in section 2.3. 
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2. Ordered membrane domains  
This chapter discusses different types of ordered membrane domains in both cells and 
model membranes. The most important ordered membrane domains in cells are called rafts 
and caveolae (a subtype of raft). One feature all these domains have in common is their 
dependence on cholesterol. Here, I will focus on ordered membrane domain structure, the 
methods of analysis and the importance of cholesterol.  
 
2.1 Membrane rafts 
Although there had been for some time evidence for the existence of lipid domains 
(Karnovsky et al., 1982) this phenomenon only started to get wider attention when Simons 
and van Meer found a functional application. They showed that NBD-glucocylceramide gets 
sorted from the Golgi to the apical membrane of epithelial cells (van Meer et al., 1987) and 
postulated the involvement of lipid domains enriched in cholesterol and sphingolipids 
(Simons  and  van  Meer,  1988).  These  lipid  domains,  termed  rafts,  started  to  get  wide  
recognition  outside  the  lipid  field  after  the  publication  of  a  review  which  described  the  
concept (Simons and Ikonen, 1997). A consensus definition of a membrane raft emerged at 
a keystone symposium in 2006 on Lipid Rafts and Cell Function (Pike, 2006): “Membrane 
rafts are small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-
enriched domains that compartmentalize in cellular processes. Small rafts can sometimes be 
stabilized to form larger platforms through protein-protein interaction”.  A  wide  array  of  
cellular processes has been shown to be mediated by rafts including membrane trafficking, 
signal transduction, cell adhesion and endocytosis. Below are discussed the main techniques 
for studying membrane rafts in cells. 
 
Studying rafts: detergent resistance, cholesterol removal and clustering  
Detergent resistance of certain lipids and proteins has been an important tool for raft 
analysis. Detergent resistance was first used to support the raft hypothesis by a study by 
Brown  and  Rose.  They  showed  that,  en route to the apical membrane, GPI anchored 
proteins become associated with a detergent resistant membrane (DRM) fraction which was 
enriched in sphingolipids (Brown and Rose, 1992).  Since then, detergent resistance has 
grown to become a useful tool for studying potential raft association of proteins, especially 
when DRM association can be triggered by a physiologically meaningful event (Lingwood 
and Simons, 2010). However, it should be noted that DRMs are artifactual entities that do 
not exist in living cells. Furthermore, detergent resistance does not always indicate raft 
association of a protein (Shogomori and Brown, 2003). 
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Another important advance in the raft field came from the discovery that deprivation of 
cholesterol decreased the detergent resistance of a glycosylphosphatidylinositol (GPI) 
anchored  protein  (Hanada  et  al.,  1995).  Later  it  was  shown  that  by  selectively  depleting  
cholesterol from the plasma membrane using the sterol carrier methyl-?-cyclodextrin 
(M?CD) the influenza virus protein hemagglutinin became excluded from DRMs (Scheiffele 
et al., 1997). Together with DRM isolation, M?CD treatment became a widely used tool to 
analyze involvement of rafts in cellular processes. This method will be critically discussed in 
section 2.4. 
Another important tool for studying rafts is by clustering raft proteins or lipids by antibodies 
or toxins. Maxfield and colleagues showed that antibody induced clustering of a GPI-
anchored receptor led to relocalization of the receptor to caveolae, a subtype of raft (Mayor 
et al., 1994).  Later the same was shown for sphingomyelin and glycolipids (Fujimoto, 1996). 
In a similar sort of experiment, simultaneous cross-linking of several membrane proteins led 
to colocalization of raft proteins and segregation of raft and non-raft proteins (Harder and 
Simons, 1997). This selective clustering of raft proteins appears to be dependent on 
cholesterol as determined by M?CD treatment (Scheiffele et al., 1997).  Another interesting 
observation was that clustering of raft proteins can initiate a signaling process that 
stimulates T-cell activation (Stefanova et al., 1991). 
 
Studying rafts: microscopy and spectroscopy  
Until 2003, 15 years after the postulation of the raft hypothesis, researches had not been 
able to demonstrate ordered membrane domains in unperturbed living cells (Munro, 2003). 
In other words, there was a lack of definite proof for the existence of rafts. A breakthrough 
in  the  raft  field  was  instigated  by  the  emergence  of  non-invasive  microscopic  and  
spectroscopic methods. Important techniques include: (1) stimulated emission depletion 
(STED) microscopy (Eggeling et al., 2009), (2) fluorescence  correlation  spectroscopy (FCS) 
(Lenne et al., 2006), (3) fluorescence resonance energy transfer (FRET) ) (Rao and Mayor, 
2005), (4) single particle tracking (Suzuki et al., 2007). These studies suggest that clusters of 
GPI-anchored proteins exist with a size of 10-200 nanometers and a sub-second life time.  
 
  
25  
2.2 Ordered domains in model membranes 
Studying lipid interactions in cells is difficult due to the complexity of cellular membranes; 
they contain hundreds of different lipids which are constantly influenced by cellular 
processes like, for instance, membrane transport. For this reason researchers started to 
utilize simple model membrane systems for studying domain behavior of lipids. 
 
Phase behavior in membranes 
Lipids in a bilayer can exist in different phases. Two common phases are the solid-ordered 
(So) and liquid-disordered (Ld) phase. Besides physical parameters such as temperature, the 
phase behavior of a bilayer depends on structural features of the lipids. One important 
feature is the melting temperature (Tm) of the lipid. Lipids with long and saturated acyl 
chains have strong intermolecular van der Waals interactions and therefore a high Tm. On 
the other hand, lipids with short cis-unsaturated acyl chains are more kinked and have 
a lower Tm. In a bilayer, lipids with a high Tm tend to form a closely packed So phase which is 
characterized by high acyl chain order and low lateral mobility. On the other hand, low-Tm 
lipids tend to form a Ld phase, characterized by low acyl chain order and high lateral 
mobility. A single membrane can exist in more than one phase. For instance binary mixtures 
containing one high and one low-Tm lipid can have So domains in an overall Ld membrane 
(Shimshick and McConnell, 1973). However, for most researchers this phenomenon did not 
explain the presence of membrane rafts since the existence of a So phase was considered 
incompatible with the view of a fluid cellular membrane. 
 
Cholesterol and the liquid-ordered phase 
Before the raft hypothesis was postulated, researchers had shown that the addition of 
cholesterol to model membranes alters their phase behavior. Cholesterol was found to 
make the Ld phase more ordered and the So phase more fluid. As a consequence, cholesterol 
enabled the formation of a new type of phase which was named liquid-ordered (Lo) (Ipsen et 
al., 1987). The Lo phase is characterized by high acyl chain order and high translational 
mobility. Because the cellular plasma membrane is roughly composed of ? cholesterol, 
? high-Tm lipids (mainly sphingolipids) and ? low-Tm lipids (mainly glycerophopholipids), 
many model membrane studies are performed with tertiary lipid mixtures of this 
composition. Using fluorescence quenching methods, such mixtures were shown to contain 
Lo ordered domains in an Ld phase (Ahmed et al., 1997; Silvius et al., 1996). Indeed, addition 
of detergent to these membranes gave rise to DRMs enriched in cholesterol and high-Tm 
lipids (Schroeder et al., 1994). During the second half of the 1990s, many researchers 
believed that the lipid interactions that form Lo domains in model membranes may cause 
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raft formation in cells (Rietveld and Simons, 1998). Today, it appears that the formation of 
rafts cannot entirely be explained by Lo phase behavior. For instance, transmembrane 
proteins that are present in rafts do not partition in Lo domains of model membranes 
(Shogomori et al., 2005). Also, it was found that clustered rafts in isolated plasma 
membranes are not in the Lo state (Lingwood et al., 2008). Nevertheless, the work in model 
membranes has convincingly illustrated that without the help of proteins, lipids are capable 
of forming ordered platforms within in a liquid phase. 
 
2.3 Caveolae  
Caveolae are often considered as a subtype of raft that are also cholesterol/sphingolipid 
enriched and resistant to detergent treatment.  Different from other membrane rafts, the 
caveolar structure is highly stable and dependent on proteins of the caveolin family. 
Caveolae are present in many types of cells, and are especially abundant in adipocytes, 
endothelial cells and muscle cells. They have been implicated in many different functions 
including endocytosis of certain lipids and virus particles, transcytosis, signaling platforms, 
adhesion and migration, and lipid regulation. 
 
Structure 
Caveolae are small flask shaped invaginations (50-100 nm in diameter) on the plasma 
membrane that can be visualized by electron microscopy (II, Figure 5A) (Palade, 1953). The 
main structural component of caveolae is caveolin-1, which is a member of the protein 
family that also comprises caveolin-2 and caveolin-3. Caveolin-1 is localized to the cytosolic 
sites of the plasma membrane with a putative hairpin intramembrane domain within the 
membrane bilayer (Parton and Simons, 2007). The importance of caveolin-1 is illustrated by 
the  findings  that  caveolin-1  knockout  cells  are  devoid  of  caveolae  (Drab  et  al.,  2001)  and  
that overexpression of caveolin-1 can (but not necessary always does) bring about the 
formation of caveolae in various cell types  (Fra et al., 1995; Lipardi et al., 1998). Caveolin-1 
has been shown to oligomerize as caveolae are formed (Monier et al., 1995) and these 
oligomers have been proposed to make up a filamentous coat which decorates the 
cytoplasmic surface of caveolae (Fernandez et al., 2002; Rothberg et al., 1992). It has been 
estimated that the number of caveolin-1 proteins per caveolae is around 150 (Pelkmans and 
Zerial,  2005).   Besides  caveolin-1  there  are  several  other  proteins  that  are  important  for  
caveolar structure. Caveolin-2 is often co-expressed with caveolin-1 but is not required for 
caveolar formation (Razani et al., 2002). Instead, caveolin-2 appears to have a modulator 
role, leading to the formation of more uniform caveolae (Li et al., 1998). Caveolin-3 is 
specifically found in muscle and appears to be both structurally and functionally similar to 
caveolin-1 (Tang et al., 1996). Recently, a protein outside the caveolin family was found to 
27  
be a structural component of caveolae (Hill et al., 2008). This protein, named cavin, was 
shown to be recruited to caveolae by caveolin-1 and is required for caveola formation and 
sequestration of mobile caveolin-1 into immobile caveolae.  
 
Cholesterol and caveolae 
As has been shown for membrane rafts, also caveolae depend structurally and functionally 
on cholesterol. Biochemically isolated caveolae have been shown to be enriched in 
cholesterol (Ortegren et al., 2004) and caveolin-1 appears to directly bind cholesterol 
(Murata et al., 1995). This interaction may be mediated by a specific cholesterol binding 
motif which is also found in other proteins (Li and Papadopoulos, 1998). Furthermore, 
cholesterol appears to be involved in caveolar biogenesis, since cholesterol stabilizes the 
formation of caveolin oligomers in vitro (Monier  et  al.,  1996)  and  is  necessary  for  loss  of  
diffusional mobility of caveolins in the Golgi (Hayer et al., 2010). Also, cholesterol appears to 
be important for caveolar structure, since the addition of filipin, a cholesterol binding 
polyene, flattens caveolae (Rothberg et al., 1992). Furthermore, cholesterol depletion by 
??CD disrupts the close proximity between caveolin-1 and cavin (Hill et al., 2008). It should 
be noted that these treatments are harsh and might affect the caveolar structure indirectly. 
Finally, it is interesting to point out that caveolae also affect cholesterol. For instance, 
overexpression of caveolin-1 leads to an increase in reverse cholesterol transport (Truong et 
al., 2010) and adipocytes from caveolin-1 knockout mice contain 10-fold reduced levels of 
cholesterol  (Le Lay et al., 2006). 
 
2.4 Studying ordered domains by cholesterol depletion 
Removal  of  cellular  cholesterol  by  cyclodextrins  has  been  one  of  the  most  widely  used  
methods for studying whether a process takes place in membrane raft/caveolae. Here, the 
procedure, side effects and the general cellular response to cholesterol removal will be 
discussed.   
 
Cholesterol depletion by methyl-?-cyclodextrin 
Cyclodextrins are synthetic cyclic oligosaccharides which have a hydrophilic exterior and 
a hydrophobic core. These characteristics allow cyclodextrins to solubilize certain 
hydrophobic compounds.  The hydrophobic core of the heptamer methyl-?-cyclodextrin 
(M?CD)  is  especially  suitable  for  solubilizing  cholesterol  (Ohtani  et  al.,  1989)  (Figure  4).  
When added to cells, M?CD efficiently removes cholesterol from the plasma membrane. 
The most common protocol for cholesterol removal prescribes incubation with 10 mM 
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??CD  for  30  min  at  37  ?C.  This  treatment  results  in  a  removal  of  ?60%  of  total  cellular  
cholesterol  in  BHK  cells  (Keller  and  Simons,  1998)  and  ?70%  in  HeLa  cells  (Vainio  et  al.,  
2006). Although the cholesterol is removed from the plasma membrane, it should be noted 
that also intracellular compartments will be affected because of continuous transport of 
cholesterol between cellular organelles (Lange et al., 2004; Rosenbaum et al., 2010).  
There are several side effects when using M?CD to remove cellular cholesterol. First, M?CD 
also extracts certain phospholipids (Ohvo and Slotte, 1996). For instance, a 30 min M?CD 
treatment of rat cerebellar granule cells resulted in a decrease of sphingomyelin (15%) and 
glycerophospholipids (17%), besides cholesterol (50%) (Ottico et al., 2003). Second, M?CD 
has been reported to extract peripheral membrane proteins from cells (Ilangumaran and 
Hoessli, 1998; Ohtani et al., 1989). Most researchers who use M?CD to study rafts neglect 
these side effects and therefore do not include proper control samples in which cholesterol 
levels are replenished after depletion.  
 
  
Figure 4. Structure of methyl-?-cyclodextrin. R = -OH or -OCH3 
 
Effect of cholesterol depletion on cells 
Since cholesterol has many cellular functions apart from forming rafts/caveolae, acute 
cholesterol removal by M?CD also affects these other processes. For instance, cholesterol 
has been shown to be important for proper membrane permeability and fluidity. Indeed, 
cholesterol depletion from cells results in increased plasma membrane permeability to small 
molecules and ions (Grunze and Deuticke, 1974). Furthermore, membrane cholesterol levels 
have been shown to also affect the functions of non-raft enzymes. It was shown that Na+/K+-
ATPase activity decreased when the cholesterol content was altered from native levels 
(Yeagle et al., 1988). Furthermore, cholesterol depletion inhibits the formation of clathrin-
coated  vesicles  (Rodal  et  al.,  1999).  Another  difficulty  in  the  interpretation  of  cholesterol  
depletion arises from the fact that certain raft mediated processes affect other cellular 
processes that do not take place in rafts. For instance, cholesterol depletion delocalizes 
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phosphatidylinositol 4,5-bisphosphate (PIP2)  from  the  plasma  membrane  (Pike  and  Miller,  
1998). PIP2 is involved in cytoskeleton/membrane interaction and actin fiber formation 
(Caroni, 2001) and thereby affects many cellular processes. Indeed, it has been shown that 
cholesterol removal affects the lateral mobility of membrane proteins by disrupting the 
interactions between PIP2 and actin (Kwik et al., 2003). Taken together, loss of a particular 
function after cholesterol depletion does not necessarily imply that this process occurs in 
membrane rafts. 
  
3. Cholesterol analogs as a tool 
Cholesterol analogs can function as valuable tools to study the biology of cholesterol. I have 
made a distinction between fluorescent and non-fluorescent cholesterol analogs since their 
use lies in distinct areas. 
 
3.1 Fluorescent cholesterol probes 
Fluorescent cholesterol analogs can be utilized to analyze the dynamic localization of sterols 
in  living  cells.  The  usefulness  of  such  probes  depends  on  two  factors:  their  fluorescent  
properties and their functional similarity to cholesterol. The labeling of lipids with 
a fluorescent group is generally more challenging than the labeling of proteins. Proteins 
often consist of distinct functional domains.  The addition of a fluorescent group outside 
these functional domains often does not interfere with the protein’s activity. On the other 
hand, most properties of membrane lipids are not mediated by distinct functional domains 
but instead follow from the physical properties of the entire molecule. Because cholesterol 
is a small molecule, most minor structural changes will have relatively large effects on the 
physical  properties  of  cholesterol.  In  this  section  the  benefits  and  drawbacks  of  the  most  
widely used fluorescent cholesterol analogs (Figure 5) will be discussed. 
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Figure 5. Structures of fluorescent cholesterol analogs. The green areas indicate the added 
fluorescent groups and the blue areas indicate the conjugated triene moiety. The BODIPY-
cholesterol analog shown is also known as BODIPY-cholesterol compound 2 (Li et al., 2006). 
 
NBD-cholesterol 
The addition of a fluorescent 7-nitrobenz-2-oxa-1,3-diazol-4-yl (NBD) group to cholesterol 
gives  rise  to  NBD-sterols  (Figure  5).  There  are  several  NBD-sterols  that  differ  by  the  
positioning of the NBD group. Most common are 22-NBD-cholesterol and 25-NBD-
cholesterol. The NBD group has relatively good fluorescent properties; excitation (470 nm) 
and emission (530 nm) are in the visible region and the quantum yield is good 
(Chattopadhyay, 1990). 22-NBD-cholesterol has been shown to interact with the sterol 
binding sites of cholesterol modifying enzymes such as HMGR (Craig et al., 1981) and ACAT. 
Furthermore, NBD-cholesterol has been used to characterize sterol binding sites of StAR 
(Petrescu et al., 2001) and SCP-2 (Avdulov et al., 1999). Even though NBD-cholesterol is 
recognized as cholesterol by many sterol binding enzymes, the biophysical properties of 
NBD-sterols in lipid bilayers are very different from those of cholesterol. Neither of the NBD-
sterols  partition  in  cholesterol  rich  domains  (Loura  et  al.,  2001;  Mattjus  et  al.,  1995).  
Moreover, NBD-sterols were shown to orient upside down in model membranes (Scheidt et 
al., 2003). Also the behavior of NBD-sterols in cells deviates much from that of cholesterol. 
For example, 22-NBD-cholesterol and 25-NBD-cholesterol both accumulate in mitochondria 
(Mukherjee et al., 1998). Altogether, because of their aberrant biophysical behavior and 
subcellular localization, NBD-sterols are unsuitable for studying the cell biology of 
cholesterol.  
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Dehydroergosterol and cholestatrienol 
Dehydroergosterol is a naturally fluorescent sterol which is synthesized in certain types of 
yeast. Structurally, dehydroergosterol closely resembles cholesterol; differing only by three 
additional double bonds and an additional methyl group (Figure 5). Cholestatrienol, an 
analog very similar to dehydroergosterol, also contains a fluorescent conjugated triene 
system but is otherwise identical to cholesterol. Because cholestatrienol is not commercially 
available, not many researchers use this compound. Therefore, the focus of this section will 
be on dehydroergosterol. As might be expected from its structural resemblance to 
cholesterol, dehydroergosterol behaves quite similarly to cholesterol. In model membranes 
the orientation of dehydroergosterol is correct, with the free hydroxyl group pointing 
towards  the  water  interphase  (Scheidt  et  al.,  2003).  Furthermore,  dehydroergosterol  has  
affinity for ordered membrane domains (Garvik et al., 2009). However there are small 
differences between dehydroergosterol and cholesterol regarding certain physical 
properties.  For instance, the sterol induced phospholipid condensation as measured by 2H 
NMR order parameters was significantly lower for dehydroergosterol (Scheidt et al., 2003). 
Nevertheless, dehydroergosterol has been used in many studies to analyze the behavior of 
cholesterol in vitro.  An  interesting  example  is  a  study  that  analyzed  sterol/protein  
interaction by measuring FRET between tryptophan residues and dehydroergosterol (de 
Almeida et al., 2004).  
Dehydroergosterol has also been shown to resemble cholesterol in vivo.  The  worm  
Caenorhabditis elegans, which needs sterol uptake in order to survive, can live and 
reproduce on dehydroergosterol (Matyash et al., 2001). Also mammalian cells are viable 
when containing dehydroergosterol as the main sterol (Kavecansky et al., 1994). 
Furthermore, the intracellular dehydroergosterol distribution resembles that of cholesterol 
as  determined  by  filipin  staining  and  sucrose  density  fractionation  (Hao  et  al.,  2002).  
Dehydroergosterol has been used in several studies to analyze intracellular cholesterol 
transport (see 1.5 Intracellular cholesterol transport). However, it should be noted that in 
cells  dehydroergosterol  does  not  behave  identically  to  cholesterol,  e.g.  its  rate  of  
esterification was shown to be 8 fold higher in fibroblasts (Frolov et al., 2000).  
A major drawback in the use of dehydroergosterol and cholestatrienol results from their 
unfavorable  spectroscopic  properties.   Excitation  and  emission  take  place  at  376  nm  and  
422 nm, respectively.  This low wavelength region is both phototoxic to cells and requires 
a special microscopic setup, suitable for UV-imaging. Another disadvantage is the poor 
image quality obtained with these probes. This is caused by the fluorophore’s low quantum 
yield (0.04 in ethanol) and high bleaching rate. Furthermore, the high sensitivity to 
photobleaching does not allow continuous imaging of the same field. To summarize, 
dehydroergosterol and cholestatrienol resemble the biophysical properties of cholesterol 
better than other fluorescent cholesterol analogs. This makes these probes highly valuable 
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for studying the cell biology of cholesterol.  However, the poor fluorescent properties of 
these probes severely restrict their use. 
 
BODIPY-cholesterol 
BODIPY-sterols are chemically synthesized analogs of cholesterol containing a covalently 
attached boron dipyrromethene difluoride (BODIPY) group.  The BODIPY group has excellent 
fluorescent properties for live cell imaging; its excitation and emission are very similar to 
that of GFP, its quantum yield is 0.9 (in membrane bilayers) and its sensitivity to 
photobleaching  is  very  low.  As  for  NBD-sterols,  there  are  different  types  of  BODIPY-
cholesterol. Here I will focus on the recently developed BODIPY-cholesterol, which has the 
BODIPY group bound to carbon-24 of the sterol side chain (Li et al., 2006) (Figure 5). 
BODIPY-cholesterol appears to mimic the behavior of cholesterol in different systems. In 
model membranes, this probe has been shown to partition in cholesterol rich ordered 
domains  (Li  et  al.,  2006;  Shaw  et  al.,  2006).  This  is  a  good  indication  for  the  biophysical  
similarity to cholesterol because, except for dehydroergosterol and cholestatrienol, none of 
the other fluorescent sterol analogs mimic this behavior.  In an atomistic simulation study, 
modeling its behavior in lipid bilayers, BODIPY-cholesterol mimicked the effect of 
cholesterol  on  acyl  chain  ordering  (Holtta-Vuori  et  al.,  2008).  Also  in  cells,  BODIPY-
cholesterol resembles cholesterol. It has been shown to partition into DRMs, suggesting its 
presence in membrane rafts. The subcellular distribution of BODIPY-cholesterol was found 
to be similar to cholesterol as judged by biochemical fractionation analysis and filipin 
staining (Holtta-Vuori et al., 2008). Furthermore, BODIPY-cholesterol accumulates in the 
lysosomes of cells lacking NPC1 in a manner similar to cholesterol (Holtta-Vuori et al., 2008). 
However, just like the other fluorescent probes, BODIPY-cholesterol does not behave 
identically to cholesterol.  For instance, compared to cholesterol, its esterification is reduced 
and its secretion enhanced (Holtta-Vuori et al., 2008). Overall, it appears that BODIPY-
cholesterol is a useful new tool for the analysis of cholesterol. Because this probe has only 
been commercially available since 2009 there are only few published studies. Still, it is 
already apparent that BODIPY-cholesterol behaves more similarly to cholesterol compared 
to NBD-sterols. One reason for this difference is the higher hydrophobicity of the BODIPY-
group, making it more similar to the natural side chain of cholesterol.   
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3.2 Structure/function analysis using cholesterol analogs 
Cholesterol analogs can be used as tools for studying the relationship between cholesterol’s 
structure and function.  The cellular functions mediated by cholesterol rely on different 
structural features. For instance, certain cholesterol modifying enzymes recognize only 
a specific region of cholesterol.  On the other hand, the interactions of cholesterol within 
lipid bilayers depend more on its overall biophysical characteristics. Knowledge regarding 
the structure/function relationship of cholesterol has been important for the design of 
fluorescent cholesterol analogs. Furthermore, because certain cholesterol analogs only 
affect specific cellular functions of cholesterol, these analogs can be useful tools for studying 
biological properties of cholesterol.   
 
Types of cholesterol analogs used for structure/function analysis 
The term cholesterol analog in principle applies to any structural derivative of cholesterol 
(Ikonen and Jansen, 2008). Here, the different types of analogs that have been used to 
analyze the structure/function relationship of cholesterol will be discussed. Cholesterol 
analogs can be divided into natural and synthetic compounds. The most widely used natural 
analogs are biosynthetic precursors of cholesterol, plant sterols (phytosterols), and 
ergosterol (the main sterol in yeast) (Figure 6). Compared to other sterol analogs (e.g. 
oxysterols, sulfonated sterols, steroid hormones, bile acids) these have no additional 
hydrophilic groups that severely alter the biophysical properties of the sterol. Instead, they 
differ from cholesterol by additional alkyl groups and/or carbon–carbon double bonds, 
thereby introducing only minor structural changes. Synthetic cholesterol analogs that have 
been useful for structure/function analysis are the stereoisomers of cholesterol called 
3-epicholesterol and ent-cholesterol (Figure 6).  3-Epicholesterol is an epimer of cholesterol 
in which the hydroxyl-group is in the ?-position instead of the normal ?-position. Ent-
cholesterol is the enantiomer (mirror image) of cholesterol, i.e. the stereochemistry of all 
chiral centers is reversed. Ent-cholesterol is a particularly useful tool since its physical 
properties in lipid bilayers are identical to cholesterol (Mannock et al., 2003). On the other 
hand, ent-cholesterol is not recognized correctly by many cholesterol interacting proteins 
(Westover and Covey, 2004).  These properties make ent-cholesterol a useful tool for 
distinguishing sterol-lipid and sterol-protein interactions. 
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Figure 6. Structures of several cholesterol analogs. Structural differences with cholesterol 
are indicated with green (stereoisomer), red (additional alkyl group) and blue (carbon-
carbon bond unsaturation) dots. Ent-cholesterol is the enantiomer of cholesterol.   
 
Insights from model membrane studies 
Studies on the effects of sterol structure on membrane properties have been carried out 
since the 60’s. Most of these studies utilized the sterols described in the previous paragraph 
and analyzed their effect on acyl chain order, membrane permeability, membrane thickness, 
and raft domain formation (Demel and De Kruyff, 1976; McMullen et al., 1996; Miao et al., 
2002; Ohvo and Slotte, 1996; Xu and London, 2000; Yeagle et al., 1988). Most studies found 
that the effect of the sterol modification was highly dependent on experimental conditions 
such as sterol concentration and the type of matrix lipids used. Therefore, it is difficult to 
compare data from different studies. However, in general it was found that structural 
modifications of cholesterol reduced the sterol mediated ordering effect on phospholipid 
acyl chains. The degree of this reduction depends on the type of modification. One 
structural feature of cholesterol that was found to be important for mediating its ordering 
effect is the smoothness of the ring structure. Lanosterol, a precursor of cholesterol, has 
three additional methyl groups attached to the sterol nucleus, making the sterol more bulky 
and less streamlined. Lanosterol was found to be poor in promoting order in phospholipid 
bilayers (Miao et al., 2002). It has been suggested that the additional methyl groups disrupt 
the van der Waals interactions between the sterol and the acyl chains. Other essential 
structural features are: the hydroxyl group on carbon-3, a rigid planar ring system, and 
a flexible hydrocarbon side chain. The degree of unsaturation of the ring system and 
alkylations and unsaturations in the sterol side chain were found to be less important 
(Mannock  et  al.,  2010).  Finally,  it  is  interesting  to  point  out  that  sterol  structure  can  also  
affect membrane curvature. It was found that cholesterol promotes domains with positive 
curvature (bulging out), whereas other sterols, like lanosterol, facilitate negative curvature 
(Bacia et al., 2005).  
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Insights from cell studies 
The effects of sterol structure have been extensively analyzed in different types of cells. The 
most popular model systems have been Mycoplasma capriolum and Saccharomyces 
cerevisiae. The prokaryote M. capriolum is a sterol auxotroph. This microorganism is useful 
for  analyzing  the  effect  of  sterol  structure  since  internalized  sterols  are  not  metabolically  
modified. Most of the sterol structure analysis in the yeast S. cerevisiae have been 
performed in the GL7 strain, which is defective in 2,3-oxidosqualene-lanosterol cyclase 
activity  (Gollub  et  al.,  1977).  Other  S. cerevisiae strains  with  defects  in  ergosterol  
biosynthesis enzymes downstream of the production of lanosterol have also been used. 
These strains are able to synthesize sterols but accumulate specific biosynthetic precursors 
of ergosterol (Parks et al., 1999). Finally, there are several studies using mutated 
mammalian cell lines that are auxotrophic for cholesterol (Rujanavech and Silbert, 1986; Xu 
et al., 2005).  
Studies  in  these  different  model  systems  have  led  to  numerous  insights  regarding  the  
effects of sterol structure on cellular functions. It was observed that sterol modifications led 
to adaptive changes in the phospholipid composition (Low et al., 1985). This was also found 
in  the  mammalian  LM  cell  line  (Rujanavech  and  Silbert,  1986).  These  results  suggest  that  
cells are able to adapt to biophysical membrane changes resulting from foreign sterols by 
modifying its fatty acid composition (Bloch, 1983). Furthermore, sterol structure was shown 
to be important for specific processes like endocytosis (Heese-Peck et al., 2002) and yeast 
cell shape and cell fusion (Aguilar et al., 2010). There are several studies that analyzed the 
ability of cholesterol analogs to support growth in cells auxotrophic for cholesterol. One 
study, using mammalian cells, showed that small modifications of the sterol side chain 
supported cell growth but that more complex modifications in the sterol nucleus or 
3-hydroxy  group  did  not  (Xu  et  al.,  2005).  Overall,  the  use  of  cell  systems  reinforced  the  
structure/function relationship found from artificial membranes studies; in general, sterols 
more  downstream  of  the  cholesterol  biosynthetic  pathway  have  a  larger  order  promoting  
effect. Based on these results, and the fact that in cyanobacteria cholesterol biosynthesis 
stops at the stage of lanosterol, Konrad Bloch argued that the further metabolism towards 
cholesterol was evolved to perfect the biological functions of the sterol (Bloch, 1989).  
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4. Oxysterol binding protein related proteins  
4.1 A conserved family of lipid transfer proteins 
Oxysterol binding protein related proteins (ORPs) are a family of lipid transfer proteins that 
are conserved from humans to yeast. Their founding member, oxysterol binding protein 
(OSBP), was identified in a search for proteins that bind oxysterols (Taylor et al., 1984).  DNA 
sequence analysis revealed that OSBP is a member of a larger family of proteins present in 
all eukaryotes (Lehto and Olkkonen, 2003). The human genome encodes, in addition to 
OSBP,   11  ORPs  which  are  named  ORP  1-11  (Lehto  et  al.,  2001)  (Figure  7).  Because  of  
differential splicing several ORP genes encode for a full length (L) and a truncated (S) splice 
variant. Based on sequence similarity the human ORP family can be divided in 6 subgroups 
(Lehto et al., 2001). Yeast, which contains 7 ORPs named Osh1-7 (Beh et al., 2001), has been 
an important model for the functional analysis of ORPs. A comprehensive study, in which all 
127 possible permutations of Osh deletion mutants were created, showed that deletion of 
all Osh genes is lethal but that expression of any individual gene ensures viability (Beh et al., 
2001). This implies that the Osh proteins share a common essential function. Although ORPs 
have been implicated in a wide range of cellular processes including cholesterol homeostasis 
and transport, this essential function in yeast has not yet been discovered. Nonetheless, 
recent functional and structural studies have provided some mechanistic insights into the 
cellular functions of ORPs. 
 
Oxysterols 
Oxysterols  are  oxidized  derivatives  of  cholesterol  that  can  be  formed  either  by  auto-
oxidation or by an enzymatic reaction. This derivation can be a hydroxyl, keton, epoxy, or 
carboxyl group.  Like cholesterol, oxysterols mainly partition in lipid bilayers but, because of 
their more hydrophilic nature, move more rapidly between membranes (Yan and Olkkonen, 
2008). They are present at concentrations usually around 1000 times lower than cholesterol 
(Brown and Jessup, 2009). Oxysterols have been shown to be involved in feedback 
regulation of cholesterol homeostasis by taking part in the SREBP signaling. 
25-hydroxycholesterol (25-HC) directly binds Insig, causing Insig to bind SCAP and retain the 
SREBP complex in the ER (Radhakrishnan et al., 2007).  Oxysterols also regulate cholesterol 
homeostasis  by  acting  as  natural  ligands  of  LXR  (Janowski  et  al.,  1996).  In  addition,  
oxysterols have been shown to effect ORP proteins. For instance, 25-HC triggers OSBP 
localization to the Golgi (Ridgway et al., 1992) and 22R-HC inhibits the lipid droplet 
localization  of  ORP2  (Hynynen  et  al.,  2009).  Although  it  is  clear  that  oxysterols  influence  
ORPs and vice versa, the functional relevance of this interaction is not understood.  
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Figure 7. Human OSBP related proteins. Key structural motifs are indicated. OSBP related 
domain (ORD), pleckstrin homology (PH) domain and two phenylalanines in an acidic tract 
(FFAT) motif. 
 
Functional analysis  
After its discovery, OSBP was thought to be involved in 25-HC mediated HMGR 
downregulation (Dawson et al., 1989). However, more in-depth analysis led to rejection of 
this theory (Nishimura et al., 2005). Since then, ORPs have been implicated in various 
cellular processes including vesicular transport, cell signaling, lipid metabolism and non-
vesicular  sterol  transport.  For  example,  Osh4  is  a  negative  regulator  of  Golgi  derived  
vesicular transport (Fang et al., 1996), OSBP regulates extracellular signal-regulated kinase 
(ERK) phosphorylation (Wang et al., 2005b) and OSBP is required for cholesterol and 25-HC 
dependent stimulation of sphingomyelin synthesis (Perry and Ridgway, 2006). In a recent 
review, Raychaudhuri and Prinz propose that ORPs might mediate at least four types of 
mechanisms (Raychaudhuri and Prinz, 2010): (1) non-vesicular sterol transport between 
membranes, (2) creating transient changes in the lipid composition of membranes, 
(3) acting as lipid sensors, (4) regulating access of certain lipids to other lipid binding 
proteins. These different mechanisms are not mutually exclusive and even a single ORP 
protein might employ more than one. Recently, several studies have added weight to the 
proposed function of ORPs as direct sterol transporters (see 4.3 Role of ORPs in sterol 
transport).  
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4.2 ORP protein domains 
OSBP related domain 
Sequence analysis revealed that the ORP family of proteins contains various functional 
domains. The family is defined by the presence of an OSBP related domain (ORD) which is 
the part of the protein that has been implicated in sterol binding. The crystal structure of 
the ORD domain of Osh4 has been solved, showing that a single sterol molecule binds within 
a hydrophobic tunnel which is covered by a flexible lid (Im et al., 2005). Because measuring 
dissociation constants requires protein purification, binding affinities have been determined 
just for a handful of ORPs.  So far, these results indicate that different ORPs bind cholesterol 
and oxysterols with different affinities. For instance, OSBP has a preference for 25-HC 
(Kd = 37 nM) over cholesterol (Kd = 173 nM) (Wang et al., 2008) and ORP2 prefers 22R-HC 
(Kd = 14 nM) over 25-HC (Kd = 3.9 µM) (Hynynen et al., 2009; Suchanek et al., 2007). A study 
using photo-cross-linking  with photo-sterols suggest that most human ORPs can bind 
sterols  (Suchanek et al., 2007). Besides sterols, the ORD has been shown to bind different 
types of phospholipids at opposite surfaces of the domain (Schulz et al., 2009). This enables 
the ORD to bind two membranes simultaneously.  
 
Pleckstrin homology domain 
Many ORPs have been shown to contain a pleckstrin homology (PH) domain. This domain 
occurs in a wide range of proteins and has been shown to bind phosphorylated derivatives 
of  PI.  The  head  group  of  PI  can  be  phosphorylated  on  various  positions  to  form  in  total  
7 different subspecies which are enriched in specific cellular compartments.  Because PIs are 
localized at the cytosolic side of biological membranes they can be used as docking sites for 
proteins  containing  a  PH  domain.  For  instance,  OSBP  is  localized  to  the  Golgi  in  a  PI(4)P  
dependent manner (Levine and Munro, 2002). For most other ORPs the specific membrane 
targeting by the PH domain is poorly understood. Partly, this can be explained by the 
observation that several ORPs need additional factors for PH-mediated membrane targeting 
(Lehto et al., 2005; Levine and Munro, 2002). Finally, it should be noted that several ORPs 
lacking a PH domain have been shown to bind to phosphorylated PIs with their ORD (Li et 
al., 2002; Wang et al., 2005a). 
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FFAT motif 
In the human ORP family, 11 splice variants have been shown to contain a two 
phenylalanines in an acidic tract (FFAT) motif. Besides in ORPs, FFAT motifs are present in 
other proteins, most of which are involved in lipid metabolism (Loewen 2003). This motif 
has been shown to bind vesicle associated membrane protein (VAMP) association proteins 
(VAPs) (Loewen et al., 2003). VAPs are conserved transmembrane proteins in the ER. The 
FFAT motif has been suggested to function as an ER targeting domain (Loewen et al., 2003). 
This has been shown for the yeast proteins containing a FFAT motif (Loewen et al., 2003). In 
mammalian cells, a FFAT motif dependency for ER targeting has been shown for ORP3 
(Lehto  et  al.,  2005)  and  CERT  (Kawano  et  al.,  2006).  However,  it  should  be  noted  that  in  
mammalian  cells  not  all  proteins  with  a  FFAT  motif  have  been  localized  to  the  ER.  Some  
studies have shown the importance of the FFAT motif for protein function. The FFAT motif in 
CERT is important for efficient traffic of ceramide from the ER to the Golgi (Kawano et al.,  
2006).  Furthermore,  it  has  been  shown  that  an  intact  FFAT  motif  is  important  for  ORP1L  
mediated positioning of late endosomes (Vihervaara et al., 2010). However, it is unknown 
whether the FFAT domain is important for ORP mediated sterol transport. For instance, 
ORPs lacking a FFAT motif have been shown to be efficient sterol transporters 
(Raychaudhuri et al., 2006). 
 
4.3 Role of ORPs in sterol transport 
Yeast 
The most important advances regarding the role of ORPs in sterol transport have come from 
studies in yeast. The genetic study that revealed a functional redundancy in the yeast ORP 
family showed that many deletion mutants exhibited specific sterol-related defects (Beh et 
al., 2001). Another study by the same group showed that removal of all Osh genes gives a 
3.5-fold increase in cellular ergosterol and alters the cellular sterol distribution as judged by 
filipin  staining  (Beh  and  Rine,  2004).  The  first  evidence  for  a  direct  role  of  ORPs  in  sterol  
transport was that Osh4 contains a hydrophobic pocket capable of binding sterols (Im et al., 
2005). Further evidence was provided in a functional study by the group of William Prinz. 
They found that Osh proteins are required for sterol transport between the plasma 
membrane  and  ER  (Raychaudhuri  et  al.,  2006).  In  a  later  publication,  the  same  group  
showed that all Osh proteins can transfer sterols between membranes in vitro (Schulz et al., 
2009). Based on these structural and functional observations the authors proposed that 
ORPs are vehicles that are able to shuttle cholesterol between two membranes.  More 
information about the mechanism of ORP mediated sterol transport was provided by 
showing  that  Osh4p  mediated  sterol  trafficking  is  dependent  on  the  ability  of  Osh4p  to  
simultaneously bind two apposed membranes (Schulz et al., 2009). Furthermore, this study 
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shows  that  most  of  the  yeast  ORPs  are  enriched  in  regions  of  the  ER  that  are  closely  
associated  with  the  plasma  membrane.  This  interaction  was  found  not  to  require  a  FFAT  
domain or Scs2p, the yeast equivalent of VAP. The authors suggest the localization of ORPs 
at membrane contact sites could explain how Osh proteins could transfer sterols rapidly 
enough to contribute to the bulk sterol transfer. However, the authors also argue that these 
observations do not exclude functional mechanisms other than direct sterol transport. 
 
Mammals 
Not  much  is  known  about  the  role  of  ORPs  in  mammalian  cholesterol  transport.  One  
difficulty  in  the  functional  analysis  of  mammalian  ORPs  results  from  the  lack  of  tools  to  
disrupt expression/function of all ORPs simultaneously. Single knockdown experiments 
would not be very informative if mammalian ORPs are functionally redundant, as Osh 
proteins in yeast are. Despite this, several studies have implicated human ORPs in sterol 
traffic. The role of ORP2 in relation to cholesterol homeostasis has been extensively studied 
by the group of Vesa Olkkonen. They made four key observations: (1) ORP2 overexpression 
increased transport of newly synthesized cholesterol to extracellular acceptors (Hynynen et 
al.,  2005),  (2)  ORP2  silencing  increased  the  amount  of  cholesterol  esters  (Hynynen  et  al.,  
2009), (3) ORP2 was shown to bind cholesterol and several oxysterols (Hynynen et al., 2009; 
Suchanek  et  al.,  2007),  (4)  ORP2  localized  to  lipid  droplets,  the  plasma  membrane,  and  
cytosol (Hynynen et al., 2009). Together these observations could be explained by a role for 
ORP2 in sterol transport from the ER to the plasma membrane.  
OSBP and ORP9L have also been implicated in sterol transport. Both proteins transfer 
cholesterol between membranes in vitro, in a PI(4)P dependent manner (Ngo and Ridgway, 
2009). These proteins were shown to localize to the Golgi and the ER, which was dependent 
on  a  functional  PH  domain  and  FFAT  motif,  respectively  (Wyles  and  Ridgway,  2004).  
Furthermore, OSBP overexpression results in increased cholesterol biosynthesis and 
a  reduction  of  cholesterol  esterification  (Lagace  et  al.,  1997)  and  ORP9  silencing  leads  to  
Golgi fragmentation and reduced filipin staining of late endosomes (Ngo and Ridgway, 
2009).  Based on these results the authors suggest that both proteins might be involved in 
cholesterol transport from ER to Golgi. However, it remains to be determined whether the 
primary function of OSBP and ORP9 is ER to Golgi sterol transport.  
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AIMS OF THE STUDY 
In this work the aim was to characterize both fluorescent and non-fluorescent cholesterol 
analogs as tools to study membrane rafts and intracellular cholesterol transport. 
Furthermore,  the  aim  was  to  use  these  new  tools  along  with  more  conventional  ones  to  
address the importance of cholesterol for ordered membrane domains and intracellular 
cholesterol transport. 
 
The specific aims of this study were: 
1. To characterize desmosterol as a tool to study ordered membrane domains 
2. To study the importance of cholesterol for caveolae by substituting cellular cholesterol 
by desmosterol 
3. To characterize BODIPY-cholesterol as a tool to analyze cholesterol transport between 
the plasma membrane, the ER and lipid droplets 
4. To utilize BODIPY-cholesterol to analyze the importance of ORPs for cholesterol 
transport between the plasma membrane, the ER, and lipid droplets in mammalian 
cells 
 
 
 
  
42  
METHODS 
Details regarding the materials and methods are provided in the original articles (I – III). 
 
1. Model membrane experiments 
Multilamellar vesicle (MLV) preparation (I) 
Lipids from stock solutions were pipetted in a glass tube (Table 1). The lipid mixtures were 
dried  by  heating  under  a  soft  flow  of  nitrogen.  In  order  to  remove  most  organic  solvent  
molecules, the mixture was further dried for 1 h in a speed vac. Phosphate buffered saline 
(PBS) was added to the dried lipid film and MLVs were generated by vortexing each sample 
4 times 30 s at 55 °C.  
 
Table 1. Lipid content of multilamellar vesicles 
Procedure Molar ratio1 DPH2 Lipid concentration (µM)  
 DPPC DOPC 12-SLPC    
Detergent resistance  1 1  - 500  
DPH quenching        
????????
????   1  1 yes 50  
?????
????   1 1  yes 50  
????????
????    1 1 yes 50  
?????
????   1  yes 50  
DPH polarization  1 1  yes 50  
1, MLVs were prepared with and without 15 mol % of cholesterol or desmosterol 
2, 1,6-diphenyl-1,3,5-hexatriene (DPH) was present at 0.5 mol % 
 
Detergent resistance of MLVs (I) 
Detergent solubilization was assayed by measuring the loss of light scattering as determined 
by  optical  density  (OD)  at  400  nm  as  done  in  (Xu  et  al.,  2001).  The  OD400 was measured 
before and after 2 h incubation with 0.5% Triton X-100 at room temperature. The detergent 
resistance (% OD) was determined by dividing the OD400 after the incubation by the OD400 
before addition of the detergent. 
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1,6-diphenyl-1,3,5-hexatriene (DPH) quenching (I) 
The procedure was performed essentially as described in (Xu and London, 2000). 
Temperature dependent DPH quenching was measured by heating the MLVs continuously 
from 21 to 56 °C at 1 °C per min while stirring the suspension. A single quenching 
experiment was performed by acquiring temperature dependent quenching curves of four 
different MLV preparations (Table 1). The 1-palmitoyl-2-(12-doxyl)stearoylphosphatidyl-
choline (12-SLPC) dependent quenching of DPH (????????
???? ) was corrected for intensity 
changes unrelated to the quencher lipid 12-SLPC (divide by ?????
????).  Next,  this  value  was  
corrected for un-quenching unrelated to domain formation by subtracting   
????????
????
?????
???? . 
Altogether, ?
?
??
 was calculated as follows. 
  ?
?
??
= ????????????
?????
???? ?
????????
????
?????
????  
The quenching curves, ?
?
??
 as a function of temperature, were fitted with sigmoidal 
Boltzmann equation as in (Wenz and Barrantes, 2003). The Tm was  derived  from  the  
halfpoint of the curves and the domain formation coefficient a was determined by 
subtracting the lower from the higher asymptote. 
 
Polarization (I) 
The fluorophore was excited with polarized light. Emission of parallel (I?) and perpendicular 
polarization (I?) was detected. Polarization was calculated as:    ? = ??????
?????    
 
2. Biochemical procedures 
Lipid extraction (I, II, III) 
Lipids were extracted by a modified method of (Bligh and Dyer, 1959). Cells were scraped in 
1.6  ml  of  PBS  and  transferred  to  a  glass  tube.  Lipids  were  dissolved  by  adding  2  ml  
chloroform and 4 ml methanol. Aggregated proteins were removed by centrifugation.  The 
solution formed two separate phases after the addition of 2 ml 2% NaCl solution and 2 ml 
chloroform.  The  lower  organic  phase  containing  the  lipids  was  collected  and  dried  by  
heating under a soft flow of N2. 
 
Sterol determination (I, II, III) 
Total sterols and sterol esters were analyzed by high performance thin layer 
chromatography (HPTLC) using a running buffer of hexane/diethyl ether/acetic acid (80:20:1 
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v/v/v). BODIPY-sterols were analyzed with a buffer of petroleum ether/diethyl ether/acetic 
acid (60:40:1 v/v/v). In order to resolve cholesterol biosynthetic precursors, the sterol 
fractions purified by thin layer chromatography (TLC) were further separated by silver ion 
high performance liquid chromatography (Ag+-HPLC). 
 
Replacing cholesterol for desmosterol using M?CD/sterol complexes (I) 
Cholesterol was depleted from Huh7 cells by 30 min incubation with 10 mM M?CD at 37 °C 
while shaking. Next, the cells were replenished with either cholesterol or desmosterol by 
incubating for 1 h with a M?CD/sterol complex (8.7:1 mol/mol) at a sterol concentration of 
50 µg/ml. 
 
Subcellular membrane fractionation (I, II) 
Cells  were collected in PBS and the samples were kept at  0-4 °C for  the remainder of  the 
procedure. After pelleting, the cells were resuspended in a hypotonic lysis buffer 
supplemented with protease inhibitors. The cells were lysed by passing them 60 times 
through a 25-gauge needle. The nuclei were removed by centrifugation and 400 µl of the 
post nuclear supernatant was collected in a SW28Ti ultracentrifuge tube. The supernatant 
was mixed with 1600 µl of lysis buffer containing 2.4 M sucrose. The sample was overlaid 
with 7 parts of 2 ml of lysis buffer containing 1.8, 1.6, 1.4, 1.2, 1.0, 0.8, and 0.6 M sucrose. 
After centrifugation at 70,000 x g for 24 h, the fractions were collected. 
 
Detergent resistant membrane isolation (II) 
Cells  were collected in PBS and the samples were kept at  0-4 °C for  the remainder of  the 
procedure. The pelleted cells were resuspended in lysis buffer containing 1% triton X-100.  
Optiprep™ was added to give a final concentration of 40% and the mixture was transferred 
to a SW60Ti ultracentrifuge tube. A step gradient of 35, 30, 25, 20, and 0% Optiprep™ was 
pipetted on top of the sample. After centrifugation at 40,000 x g for 4 h, the fractions were 
collected. DRMs were present in the top fraction. 
 
Immunoisolation of caveolar membranes (II) 
Adipocytes were prepared from epididymal fat pads of male Wistar rats. The fat pads were 
digested in Krebs-Ringer-HEPES buffer containing collagenase at 37 °C for around 1 h. The 
cells were filtered through a 200-µm nylon mesh and washed in Krebs buffer. Cells were 
incubated for 2 days in the presence of [14C]cholesterol, [3H]desmosterol and 20,25-DAC.  
Subsequent steps were carried out at 0-4 °C.  Cells were collected, resuspended in lysis 
45  
buffer and broken by 10 strokes with a dounce homogenizer.  Nuclei and unlysed cells were 
removed by centrifugation at 1000 x g and a plasma membrane containing pellet was 
obtained by centrifugation at 16,000 x g. The pellet was resuspended in 2 ml of 500 mM 
sodium carbonate (pH 11) and membranes were disrupted by sonication.  The homogenate 
was transferred to a SW40Ti tube and sucrose was added to a final concentration of 45% 
sucrose. The mixture was overlaid with 4 ml of lysis buffer containing 35% and 5% sucrose 
and centrifuged for 24 h at 39,000 x g. The caveolar enriched fraction at the 5-35% sucrose 
interphase was divided and incubated overnight with and without caveolin-1 antibodies. 
The antibody complexes were precipitated using Dynal beads linked to anti-mouse IgG. The 
amount of radioactivity that co-precipitated was corrected for the unspecific pulldown in 
the samples without caveolin-1 antibodies.  
 
Lipid droplet isolation (III) 
Lipid droplets were isolated as described in (Brasaemle and Wolins, 2006). Oleate loaded 
HeLa cells were collected and kept at 0-4 °C for the remainder of the procedure. The cell 
pellet was resuspended in a hypotonic lysis buffer containing protease inhibitors. Nuclei 
were removed by centrifugation for 10 min at 1000 x g. The post nuclear supernatant was 
transferred to a SW40Ti ultracentrifuge tube and adjusted to 20% sucrose. The samples 
were overlaid with 5% sucrose and 0% sucrose in lysis buffer. The samples were spun for 2 h 
at 28,000 x g. The lipid droplet fraction, which was visible at the top of the gradient as a 
milky white layer, was collected with a tube slicer. 
 
N,N,N-trimethyl-4-(6-phenyl-1,3,5-hexatrien-1-yl)phenylammonium (TMA-DPH) anisotropy 
(II) 
The  plasma  membrane  fluidity  of  living  cells  was  analyzed  as  in  (Kuhry  et  al.,  1985).  
A suspension of trypsinized cells was mixed with the fluorescent probe TMA-DPH, which 
selectively localizes to plasma membranes. The fluorophore was excited with polarized light. 
Emission of parallel (I?) and perpendicular polarization (I?) was detected. Anisotropy was 
calculated as:    ? = ??????
??????    
 
[3H]cholesterol esterification (III) 
This procedure was performed as reported (Huang et al., 2003). The plasma membranes of 
oleate loaded HeLa cells were labeled with [3H]cholesterol from a bovine serum albumin 
(BSA) complex for 30 min at 15 °C. Next, the cells were incubated for different times at 37 °C 
after which the lipids were isolated. [3H]cholesterol and [3H]cholesterol esters were 
analyzed by TLC and scintillation counting. 
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3. Fluorescence microscopy assays 
The following microscopy assays were performed either on fixed or living cells.  For fixation, 
cells were grown on coverslips, incubated with paraformaldehyde and mounted on a glass 
slide.  The  live-cell  microscopy  experiments  were  performed  at  37  °C  in  CO2 independent 
medium, which kept the cells at physiological pH outside a CO2 rich atmosphere of  five to 
ten percent. 
 
Quantification of caveolin-1-GFP mobility by TIRF microscopy (II) 
The transport of caveolae to and from the plasma membrane was measured as reported 
(Tagawa  et  al.,  2005).   HeLa  cells  expressing  caveolin-1-GFP  were  analyzed  by  TIRF  
microscopy. Mobile caveolae are visible as appearing and disappearing dots in the TIRF 
plane. Movies (4 frames per min) were made of the caveolar fluorescence in the TIRF plane. 
The Pearson’s correlations of consecutive images were calculated and averaged. Lower 
correlation indicates more change between images and therefore higher mobility. 
 
Caveolin-1 composition of caveolae (II) 
High resolution TIRF microscopy images were taken of HeLa cells stably overexpressing 
caveolin-1 GFP.  Image quality was improved by deconvolution, using Huygens image 
restoration software. The intensities of the dots were determined using automated spot 
detection and fitting their intensity as a function of x and y, with a normal distribution. The 
intensity histogram of the dots revealed Gaussian shaped intensity groups representing the 
intensities of individual caveolae (first group) and caveolar clusters. The first three intensity 
groups were fitted with a mixture of three univariate Gaussian distributions. The width of 
the first peak was taken as a measure of variation in the amount of caveolin-1 molecules per 
caveolae.  
 
BODIPY-cholesterol labeling of cells (III) 
Cells were incubated with a M?CD/BODIPY-cholesterol complex for 1 min at 37 °C in serum 
free  medium.  It  was  determined  by  HPTLC  that  this  procedure  labeled  the  cells  with  
1 molecule of BODIPY-cholesterol for every 1000 molecules of natural cholesterol. The 
complex was prepared by adding a 370 mM M?CD solution to solid BODIPY-cholesterol to 
reach a 100:1 molar ratio. The complexes were formed by sonicating the mixture 6 times 
2 min on ice. Uncomplexed BODIPY-cholesterol crystals were spun down by centrifugation.  
47  
BODIPY-cholesterol pulse chase experiments (III) 
HeLa cells were pre-labeled with either BODIPY-C12 (lipid droplet marker) or ER-tracker.  
Next, the cells were labeled with BODIPY-cholesterol followed directly by live-cell imaging 
using a confocal microscope. Three channel images were taken by sequential scanning using 
three different laser lines:  BODIPY-cholesterol 488 nm, the organelle markers 561 nm, 
HcRed (marker for transfected cells) 633 nm. The focal plane was aimed ?1 µm above the 
basal plasma membrane. Images were taken continuously for up to 3 h to analyze the 
kinetics of transfer. In experiments where treatments were compared to controls, 6-9 
images were taken at 15-25 min after chase and 6-9 images after 180 min. Colocalization, as 
expressed by the Pearson’s correlation, was calculated between BODIPY-cholesterol and the 
organelle  marker.  This  value  was  used  as  a  measure  of  the  relative  amount  of  BODIPY-
cholesterol in the organelle. 
 
Dehydroergosterol pulse chase (III) 
Huh7 cells were pre-labeled with the lipid droplet marker BODIPY-C12, and then labeled with 
a  M?CD/dehydroergosterol  complex  (molar  ratio  8:1)  for  3  min  at  37  °C  as  described  
(Wustner et al., 2002). The label was chased for 45 min before imaging with a wide field 
microscope, equipped with filters and a dichroic mirror suitable for dehydroergosterol 
imaging.  
 
Fluorescence recovery after photobleaching of BODIPY-cholesterol in lipid droplets (III) 
HeLa cells, pre-labeled with the lipid droplet marker BODIPY-C12, were labeled with BODIPY–
cholesterol, which was equilibrated by chasing for 2 h. The BODIPY fluorescence in a cluster 
of immobile lipid droplets was bleached with 5 short pulses (1.5 sec in total) of the 488 nm 
argon  laser  line  at  full  power.  Before  and  after  bleaching,  this  area  was  imaged  at  low  
intensity illumination with scanning settings that favor fast acquisition: high zoom factor (6), 
low resolution (256 x 256 pixels) and high scanning speed (1400 Hz).  
 
Endocytosis of BODIPY-lactosylceramide (II) 
The endocytosis of BODIPY-lactosylceramide was analyzed as described (Singh et al., 2003). 
For this experiment, primary human fibroblasts were used because of their high caveolae 
content. Cell were labeled with BODIPY-lactosylceramide at 0 °C and imaged with a wide-
field microscope to determine labeling efficiency. Next, caveolae were allowed to internalize 
the label by incubating the cells for 5 min at 37 °C.  Most uninternalized label was removed 
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by washing the cells extensively with PBS containing BSA at 0 °C.  The cells were again 
imaged by fluorescence microscopy. Internalized BODIPY-lactosylceramide was visible as 
dots. The homogenous intensity of the BODIPY-lactosylceramide that remained on the 
plasma membrane was removed by image processing using a rolling ball background 
subtraction.  
 
Endocytosis of integrins (II) 
This  procedure  was  performed  as  published  (Upla  et  al.,  2004).  HeLa  cells  expressing  
caveolin-1-GFP were incubated with antibodies against ?2 integrin for 1 h on ice. Cells were 
subsequently incubated with Alexa Fluor 568-conjugated secondary antibodies resulting in 
clustering of ?2 integrin. The clustered integrins were allowed to internalize by incubating 
the samples for 5 and 15 min at 37 °C. The samples were fixed and analyzed by confocal 
microscopy. Caveolar internalization of clustered integrins was assessed by determining the 
Pearson’s correlation coefficient between caveolin-GFP and the Alexa Fluor 568-conjugated 
antibodies.  
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RESULTS AND DISCUSSION 
1. Desmosterol as a tool to study ordered membrane domains 
1.1 Desmosterol cannot fully replace cholesterol in ordered membrane domains  
Ordered domains in model membranes 
Three biophysical experiments were performed in order to compare the ordered membrane 
domain stabilizing properties of desmosterol with those of cholesterol. Multilamellar 
vesicles (MLVs) were used, composed of DPPC and DOPC in a 1:1 molar ratio with or without 
15 mol % sterol. When high-Tm DPPC  (42  ?C)  and  low-Tm DOPC  (-20  ?C)  are  mixed,  DPPC-
enriched ordered domains coexist with DOPC-enriched disordered domains. In the following 
three experiments the effect of sterol addition on ordered domain formation and 
stabilization was measured. 
(1) The detergent resistance of the MLVs was determined by measuring the light scattering 
of the vesicles before and after addition of Triton X-100. A previous study has shown that 
the percentage of remaining light scattering roughly approximates the amount of DRMs in 
the vesicles (Xu and London, 2000). Addition of cholesterol to the MLVs resulted in a fivefold 
increase of the remaining light scattering (I, Figure 1A), in agreement with a previous study 
(Xu and London, 2000). Compared to cholesterol, desmosterol was 75% less efficient in 
promoting detergent insolubility. These results indicate that MLVs that contain desmosterol 
have a reduced fraction of DRMs.  
(2) The potential of both cholesterol and desmosterol to promote membrane ordering was 
analyzed by measuring the polarization of the fluorescent probe DPH, which was added in 
trace amounts to the MLVs. The degree of DPH polarization is positively related to the 
ordering of the lipids within the MLVs. The addition of both cholesterol and desmosterol 
increased DPH polarization in the MLVs (I, Figure 1B). However, the effect of desmosterol 
was significantly weaker compared to cholesterol. 
(3) A DPH fluorescence quenching assay was used to determine the effect of cholesterol on 
the formation and stability of ordered domains. The MLVs used for this experiment 
contained trace amounts of DPH, and DOPC was replaced by 12-SLPC. The phase behavior of 
12-SLPC is similar to DOPC, but its additional nitroxide group is capable of quenching DPH 
fluorescence.  At room temperature, these vesicles laterally segregate in a DPPC enriched 
ordered phase and a 12-SLPC enriched disordered phase. DPH has a similar affinity for both 
phases. The DPH present in the ordered phase, which is depleted of 12-SLPC, is not 
quenched. Raising the ambient temperature causes the ordered DPPC domains to melt and 
mix with the disordered 12-SLPC phase. Consequently, the probability of an interaction 
between DPH and 12-SLPC increases, resulting in higher quenching (I, Figure 1C). Addition of 
cholesterol to the membranes increased the degree of domain formation as expressed by a 
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(I, Figure 1D). The ability of desmosterol to increase unquenching was significantly lower. 
Next, the Tm of the ordered domains in MLVs containing cholesterol, desmosterol, or no 
sterol was determined (I, Figure 1E). Addition of cholesterol increased the melting 
temperature by 3 °C, indicating higher ordered domain stability. On the contrary, 
desmosterol did not significantly increase the Tm.  
 
Atomic scale molecular dynamics simulations 
To better understand why the biophysical properties of desmosterol in membranes differ 
from those of cholesterol, atomic scale molecular dynamics simulations were performed. 
The properties of DPPC bilayers in the fluid phase with and without 20 mol % cholesterol or 
desmosterol were studied. The sterol-dependent ordering of lipid hydrocarbon chains was 
assessed by determining the molecular order parameter, -SCD (I, Figure 6A). Whereas both 
sterols were found to increase acyl chain order, the effect of desmosterol was 50% lower as 
compared to cholesterol. Analysis of the orientation of the lipids showed that desmosterol 
did  not  straighten  the  acyl  chains  as  much  as  cholesterol  (I, Figure 6B). Furthermore, 
desmosterol itself was more tilted in the membrane, as compared to cholesterol (I, Table 2; 
I,  Figure  7).  To  study  the  molecular  mechanisms  responsible  for  the  difference  of  
desmosterol, experiments were focused on the conformation of the sterol tail and its 
interactions with the acyl chains. The molecular order was lower in the entire tail region of 
desmosterol (I, Figure 6C). This was associated with a 120° difference in the probabilities of 
torsion angles of the bond between carbons 17-20 (I, Figure 6D). It thus appears that the 
double bond in the tail of desmosterol changes the shape and flexibility of the tail region as 
compared to cholesterol. Consequently, the van der Waals interactions of the desmosterol 
tail with the hydrocarbon chains of the DPPCs should be different from those of cholesterol. 
Surprisingly, the van der Waals interactions of the last four atoms of the tail with DPPC acyl 
chains were found to be stronger for desmosterol. However, at the beginning of the tail the 
effect was opposite, as the acyl chains packed better around that part of the tail of 
cholesterol than desmosterol.  
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Replacing cholesterol with desmosterol in cellular membranes 
In order to investigate the effect of desmosterol on ordered membrane domains in cells, 
three different protocols were used to exchange cellular cholesterol by desmosterol. 
(1) For the first method, Chinese hamster ovary (CHO) cells were used. These cells naturally 
accumulate some desmosterol while synthesizing cholesterol. When grown in medium 
containing lipoprotein depleted serum (LPDS), these cells can accumulate 10% of 
desmosterol relative to the total unesterified sterol content. This method provides a natural 
way to study desmosterol in cells. 
(2)  In  the  second  method,  the  cellular  cholesterol  was  removed  with  M?CD  and  was  
replaced with desmosterol from a M?CD complex (I, Figure 4A). By incubating Huh7 
hepatoma cells for 30 min with 10 mM M?CD at 37 ?C, 70% of the cellular free cholesterol 
was depleted. Immediately thereafter, the cells were replenished with either desmosterol 
or cholesterol from a M?CD complex, restoring the cellular sterol content to the starting 
level. This method allows for the acute exchange of most cellular cholesterol by 
desmosterol. It should be noted that the replaced desmosterol is metabolized by the cell; 
1 h after the exchange ?10% of the desmosterol was converted to cholesterol. 
(3)  In  the  third  method,  cellular  cholesterol  was  exchanged  for  desmosterol  by  
pharmacological inhibition of 24-dehydrocholesterol reductase (DHCR24), the enzyme that 
converts desmosterol to cholesterol. HeLa cells were cultivated for 1 week in medium 
containing LPDS with and without 10 nM 20,25-diazacholesterol (20,25-DAC), an inhibitor of 
DHCR24.  This  treatment  resulted  in  a  cellular  desmosterol  content  of  90%  (II,  Figure  1B) 
without changing total sterol levels or leading to detectable accumulation of other sterols 
(II, Figure 1A). If the cells were grown in normal serum (containing cholesterol), 20,25-DAC 
gave hardly any accumulation of desmosterol, indicating that under these conditions HeLa 
cells acquire most of their sterol from the medium. 
 
Membrane rafts 
It was analyzed whether desmosterol perturbs the structure and function of ordered 
membrane  domains  in  cells.  In  CHO  cells,  the  detergent  solubility  of  desmosterol  and  
cholesterol in a plasma membrane enriched fraction (membranes with the density of 0.7-0.9 
M sucrose) was determined (I, Figure 3A). This fraction was treated with 0.5% Triton X-100, 
and  the  low  density  DRMs  were  separated  from  the  solubilized  membranes  on  
a discontinuous sucrose density gradient as described (Arreaza et al., 1994). The amount of 
cholesterol and desmosterol was analyzed from the DRM and solubilized membrane 
fraction by Ag+-HPLC. The desmosterol/cholesterol ratio was found to be more than three 
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times higher in the soluble membranes than in DRMs (I, Figure 3B). This result suggests that 
the affinity of desmosterol for membrane rafts is lower as compared to cholesterol. 
Next, it was analyzed whether raft dependent signaling was effective in Huh7 cells in which 
cholesterol was replaced by desmosterol using M?CD. It has been shown before that in 
Huh7 cells, insulin treatment triggers insulin receptor association with DRMs and that 
receptor autophosphorylation is dependent on rafts (Vainio et al., 2002). In cells containing 
desmosterol, the insulin receptor did not get associated with DRMs and its tyrosine 
phosphorylation, as determined by immunoblotting, was ?60% decreased (I, Figure 5A,C). It 
was analyzed whether this result could be explained by decreased plasma membrane 
localization  of  insulin  receptors.  This  appeared  not  to  be  the  case,  since  total  [125I]insulin 
binding was unaltered by the sterol exchange (I, Figure 5B). Therefore, these results suggest 
that the defective insulin receptor activation is related to the weaker membrane ordering 
effect of desmosterol. 
 
1.2 Desmosterol can replace most cellular functions of cholesterol  
The effect of replacing cholesterol by desmosterol on cellular functions unrelated to 
ordered membrane domains was analyzed. Initially, it was observed that the viability and 
growth rate of 20,25-DAC treated HeLa cells was not altered, as compared to control cells. 
This  suggests  that  desmosterol  can  replace,  at  least  partly,  the  essential  functions  of  
cholesterol in cells. Next, the effects of sterol replacement on more specific functions 
mediated by cholesterol were analyzed. 
 
Subcellular sterol distribution 
The  specific  distribution  of  cholesterol  over  different  cellular  membranes  is  known  to  be  
essential for the cellular functions relying on cholesterol. In order to analyze whether the 
subcellular distribution of desmosterol is similar to that of cholesterol, the fluorescent 
cholesterol binding antibiotic filipin was utilized. Both the M?CD and the 20,25-DAC 
mediated sterol exchange did not change the filipin staining pattern (I, Figure 4B; Figure 8). 
As an alternative method, the subcellular sterol distribution was determined by sucrose 
density fractionation analysis. As expected, most sterols were found to be present in low 
density fractions that also contained caveolin-1, a protein enriched in the plasma 
membrane. Only a small amount of cholesterol was found in high density fractions together 
with calnexin, an ER marker. No difference was found between the relative density 
distribution of desmosterol and cholesterol (I, Figure 3A; II, Figure 2B). Together, these 
results demonstrate that the subcellular distribution of desmosterol is similar to that of 
cholesterol.  
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Figure 8. Epifluorescence images of HeLa cells stained with filipin. Shown are control cells 
(cholesterol) and cells treated with 20,25-DAC (desmosterol). The images were deconvolved 
with Huygens deconvolution software (SVI). Scale bar: 10 µm. 
 
The Golgi and the secretory pathway 
The structure and function of the Golgi apparatus have been shown to be dependent on 
cholesterol levels (Grimmer et al., 2005). Therefore, the effects of the sterol exchange on 
Golgi morphology and albumin secretion were analyzed. M?CD mediated sterol depletion of 
Huh7 cells perturbed the morphology of the Golgi complex as judged by fluorescein 
isothiocyanate-lentil lectin staining (I,  Figure  4B).  Replenishing  the  cells  with  either  
cholesterol or desmosterol restored the Golgi staining pattern.  
To determine whether the secretory function of the Golgi was affected by the sterol 
exchange, albumin secretion was analyzed. Immediately after performing the M?CD 
mediated sterol exchange, the cells were incubated for 1 h in fresh medium. The secreted 
albumin was analyzed by Western blotting (I, Figure 4C). The results indicated that similar 
amounts of albumin were secreted from cells containing cholesterol or desmosterol. 
 
Phospholipid composition and membrane fluidity 
Various  studies  have  shown  that  sterol  structure  can  modify  the  cellular  phospholipid  
composition (Low et al., 1985; Rujanavech and Silbert, 1986). In 20,25-DAC treated HeLa 
cells,  the  cellular  composition  of  PC,  PE,  PS  and  sphingomyelin  was  analyzed  by  mass  
spectroscopy (Figure 9). Desmosterol did not alter the cellular amounts of these lipids nor 
their acyl chain length and unsaturation. 
Plasma membrane fluidity is important for proper functioning of the cell and is known to be 
dependent on cholesterol. To analyze plasma membrane fluidity, TMA-DPH fluorescence 
anisotropy (similar to fluorescence polarization) was measured in HeLa cells. When added to 
cells, the probe TMA-DPH localizes selectively to the plasma membrane (Kuhry et al., 1985). 
Hela cells containing either desmosterol or cholesterol gave identical anisotropy values 
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(0.32±0.01 and 0.32±0.01, mean±S.D., n = 3), suggesting that the overall plasma membrane 
fluidity was not altered. In comparison, inhibition of sterol biosynthesis (by 10 µM 
lovastatin, 100 µM mevalonate in LPDS for 3 days) resulted in increased membrane fluidity, 
as indicated by lower anisotropy (0.29±0.01).  
 
Figure 9. Phospholipid composition of 20,25-DAC treated HeLa cells. A) Quantification of 
the major classes of membrane lipids in HeLa cells grown for 8 days in LPDS or FBS with or 
without 10 nM 20,25-DAC (mean±S.E.; PC, PE, PS, sphingomyelin (SM), n = 3; sterol, n = 5). 
B) Quantification of phospholipid molecular species in cells grown as in (A).  The  most  
abundant species constituting at least 70% of each phospholipid class are shown, the 
numbering indicates the total number of carbon atoms and unsaturations in the acyl chains 
(mean±S.E.; PC, PE, and PS, n = 3; SM, n = 2). 
 
1.3 Using desmosterol to analyze caveolae 
Desmosterol has reduced affinity for caveolae 
Sterol association with caveolar membranes was determined by labeling cells with 
[14C]cholesterol and [3H]desmosterol followed by immunoisolation of caveolar membranes. 
For this experiment, primary adipocytes were used because of their high caveolar content 
(Parton and Simons, 2007).  Cells were labeled for 2 days with both [3H]desmosterol and 
[14C]cholesterol  in  the  presence  of  10  nM  20,25-DAC  to  prevent  the  conversion  of  
[3H]desmosterol. The cellular membranes were disrupted by sonication and subjected to 
sucrose density gradient fractionation (II, Figure 3A). The fraction enriched in plasma 
membrane, was used for isolation of caveolar membranes by immunoprecipitation using 
caveolin-1 antibodies. Both [3H]desmosterol  and  [14C]cholesterol specifically precipitated 
with caveolin-1 antibodies (II,  Figure  3B).  However,  the  amount  of  co-isolated  
[3H]desmosterol  was 35% lower than that  of  [14C]cholesterol. These results indicate lower 
affinity of desmosterol than cholesterol for caveolar membranes. 
 
55  
Caveolar stability 
The effect of desmosterol on the stability of caveolae was determined by analyzing the 
detergent and heat resistance of caveolin-1 oligomers. In HeLa cells, in which cholesterol 
was replaced by desmosterol by 20,25-DAC treatment, the amount of caveolin-1 in DRMs 
was decreased by 50% (II, Figure 3C). This effect was reversed when the cells were grown in 
FBS indicating that 20,25-DAC did not act unrelated to the sterol exchange.  
Caveolae are structurally composed of caveolin-1 oligomers (Monier et al., 1995; Rothberg 
et al., 1992) that can be analyzed as high molecular weight protein complexes by Western 
blotting using caveolin-1 antibodies.  Their stability can be assessed by analyzing the fraction 
of oligomers remaining after boiling the samples in the presence of sodium dodecylsulfate. 
It was found that 8±8% (mean±S.D.) of caveolin-1 immunoreactivity remained as heat-
resistant oligomers in desmosterol cells as compared to 43±6% in cholesterol cells (II, Figure 
3D).   
It is known that the detergent resistance and the oligomerization of caveolin-1 are related 
to its plasma membrane localization. Consequently, these results could be explained by an 
altered subcellular distribution of caveolin-1. It was analyzed whether the sterol exchange 
effects the subcellular distribution of caveolin-1 using immunofluorescence microscopy and 
sucrose density fractionation (II, Figure 2A,B). The sterol exchange did not affect the 
caveolin-1 distribution. Therefore, it seems likely that the decrease in detergent resistance 
and  the  oligomer  stability  of  caveolin-1  results  from  the  lower  affinity  of  desmosterol  for  
caveolae.  
 
Caveolar morphology 
The morphology of caveolae was analyzed by immunoelectron microscopy using antibodies 
against caveolin-1. As expected, this antibody detected uncoated invaginations in the 
plasma membrane (II, Figure 5A). The morphology of uncoated membrane invaginations 
was determined in primary human fibroblasts. In desmosterol-containing cells, uncoated 
plasma membrane invaginations with small openings (20–45 nm) were less abundant 
(II, Figure 5A; II,  Table  1).  Furthermore,  there  was  an  increase  in  the  average  width  and  
depth of the invaginations. The most prominent difference in desmosterol cells was an 
increased variation in all the measured dimensions. This difference was not observed if the 
cells were allowed to take up cholesterol from the medium, indicating that the drug was not 
directly responsible for the altered morphology. These results imply that the sterol 
exchange results in larger invaginations with higher morphological variation. 
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Caveolin-1 composition of caveolae  
In  a  previous  study,  the  caveolin-1  composition  of  caveolae  was  analyzed  in  HeLa  cells  
expressing caveolin-1-GFP (Pelkmans and Zerial, 2005). The cells were imaged by total 
internal reflection fluorescence (TIRF) microscopy, a technique that allows selective 
visualization of fluorescence on the plasma membrane. The authors found that fluorescence 
intensity of the imaged dots was distributed in quantum units of 144 Caveolin-1 molecules; 
1 unit structures were identified as individual caveolae and structures composed of multiple 
units as caveolar clusters. Using the same cell line and procedure, the clustering behavior of 
caveolae was analyzed in cells in which cholesterol was replaced by desmosterol using 
20,25-DAC (II, Figure 4).  Caveolae clustered similarly in cholesterol and desmosterol 
containing cells. However, the range of fluorescence within individual caveolae was found to 
be ?30% larger in desmosterol cells (II,  Figure  4C).  This  can  be  explained  by  a  higher  
variation in the number of caveolin-1-GFP molecules per individual caveola. 
 
Caveolar endocytosis 
Caveolae continuously pinch off and fuse with the plasma membrane. This phenomenon can 
be analyzed in HeLa cells stably expressing caveolin-1-GFP. As visualized by TIRF microscopy, 
dots appear and disappear on the plasma membrane (II,  Figure  6A).  Without  any  
stimulation,  the  rate  of  appearance  and  disappearance  of  dots  was  similar  to  the  rate  in  
cells containing desmosterol.  The caveolar mobility could clearly be stimulated by the 
dephosphorylation inhibitor vanadate, which increased tyrosine-14 phosphorylation of 
caveolin-1. After vanadate stimulation, the caveolar mobility was also similar in desmosterol 
and cholesterol containing cells.  
Next,  the  effect  of  desmosterol  on  the  endocytosis  of  a  ligand  was  analyzed.  Previous  
studies have shown that the fluorescent sphingolipid BODIPY-lactosylceramide is selectively 
internalized by caveolar endocytosis (Singh et al., 2003). Fibroblasts were labeled with 
BODIPY-lactocylceramide,  which  was  allowed  to  internalize  for  5  min  at  37  °C.  
Uninternalized label was removed from the plasma membrane by BSA washing and the 
remaining intensity quantified (II, Figure 6B). Desmosterol cells showed a moderate but 
significant reduction in BODIPY-lactocylceramide uptake.  
In an alternative approach to analyze caveolar endocytosis, the caveolar internalization of 
crosslinked integrins was determined. This was measured by determining the time 
dependent colocalization between caveolin-1 and croslinked ?2-integrin as described (Upla 
et al., 2004). The sterol exchange resulted in a slight but significant reduction in the 
colocalization, suggesting a decrease in caveolar endocytosis of integrins (II, Figure 7A). In 
comparison, no inhibition was detected in the internalization of the fluid-phase tracer 
dextran or transferrin, a marker of clathrin-mediated endocytosis (II, Figure 6C).  
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Caveolin phosphorylation 
Integrin cross-linking is known to induce caveolin-1 phosphorylation at tyrosine-14, which is 
required for caveolar endocytosis (Nomura and Fujimoto, 1999). Contrary to our 
expectations, caveolin-1 phosphorylation upon integrin cross-linking was more pronounced 
in desmosterol cells (II, Figure 7B). The mechanism underlying the increased caveolin-1 
phosphorylation in desmosterol cells was addressed using an inducible MDCK cell line 
overexpressing Src, the kinase that phosphorylates caveolin-1. Both in the basal and Src-
induced states, the caveolin-1 tyrosine-14 phosphorylation was found to be more 
pronounced in desmosterol cells (II, Figure 8). This increase appeared to be selective for 
caveolin-1 since the overall degree of tyrosine phosphorylation was not significantly altered. 
 
1.4 Discussion 
Desmosterol cannot fully replace cholesterol in ordered membrane domains 
This study provides the first evidence that the potential of desmosterol to support ordered 
domains in both model membranes and in cells is significantly lower than that of 
cholesterol. Three model membrane experiments showed that the potential of desmosterol 
to form and stabilize ordered domains is weaker than that of cholesterol. This result was 
reinforced by atomic scale simulations that indicated that desmosterol has a lower ordering 
effect in a DPPC membrane. Furthermore, the simulations showed that the double bond in 
the hydrocarbon tail of desmosterol gives rise to an additional stress in the tail, thus 
changing its conformation at the beginning of the tail, as compared with cholesterol.  This 
seemingly minor difference had large implications for various structural properties of the 
bilayer, in particular membrane order. Several months after the publication of these results, 
another study confirmed the present observation that desmosterol is weaker than 
cholesterol in stabilizing ordered domains (Megha et al., 2006). 
The present data show that the sterol exchange also affects the structure and function of 
ordered membrane domains in cells. A relatively low desmosterol content was observed in 
DRMs suggesting a low affinity of desmosterol for membrane rafts. Furthermore, 
cholesterol replacement was found to perturb both raft association and phosphorylation of 
the activated insulin receptor. Since insulin signaling has been shown to be dependent on 
rafts (Vainio et al., 2002), these results suggest that desmosterol perturbs insulin signaling 
by destabilizing membrane rafts.  
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Desmosterol can replace most cellular functions of cholesterol 
Cells  containing  desmosterol  as  the  main  sterol  behave  normally  with  respect  to  cell  
growth/viability, subcellular sterol distribution, Golgi integrity, secretory pathway, 
phospholipid composition, and membrane fluidity. Because all these processes are affected 
by M?CD cholesterol depletion, our results indicate that desmosterol can replace most non-
raft functions of cholesterol. This is in agreement with earlier studies: (1) DHCR24 knockout 
mice that contain desmosterol as the main sterol are viable (Wechsler et al., 2003) and (2) in 
mutant CHO cells desmosterol supports growth equally well as cholesterol (Xu et al., 2005). 
It is important to point out that the present results do not imply that desmosterol can 
mediate all cellular functions of cholesterol besides those in ordered membrane domains. 
However, it is clear that alternative techniques used to disrupt ordered membrane domains, 
including M?CD cholesterol depletion, are far more harmful for cells. Together, the results 
in this thesis show that exchanging cholesterol for desmosterol provides a gentle and 
selective procedure for disrupting ordered membrane domains in cells.  
 
Using desmosterol to analyze caveolae  
The importance of cholesterol for the structure and function of caveolae was investigated 
by exchanging cellular cholesterol by desmosterol. The data demonstrated that the double 
bond in desmosterol reduced its affinity for isolated caveolae. It is important to note that 
this  result  does  not  inform  about  the  actual  caveolar  sterol  content  in  cells  that  contain  
primarily desmosterol. The sterol exchange reduced the stability of caveolae as determined 
by detergent resistance of caveolin-1 and heat resistance of caveolin-1 oligomers.  Also, the 
sterol exchange led to aberrations in the caveolar structure; the morphology of caveolae 
was severely altered and there was a larger variation in the amount of caveolin-1 molecules 
per caveola. Because caveolin-1 has been shown to be involved in membranes bending (Fra 
et al., 1995) the larger variation of caveolin-1 might cause the altered morphology. 
Alternatively, sterols themselves have been implicated in membrane curvature (Bacia et al., 
2005), and therefore the double bond in desmosterol or an altered caveolar sterol content 
might have caused the altered shape of the invaginations. 
Analysis of caveolar endocytosis suggested that the sterol exchange led to a moderate 
defect in the selective uptake of both BODIPY-lactocylceramide and cross-linked integrins. It 
is unlikely that this decreased uptake resulted from an inability of caveolae to pinch off from 
the plasma membrane, since both the steady state and the vanadate stimulated caveolar 
mobility were found to be unaffected by the sterol exchange. The decreased uptake was 
neither explained by a reduction of caveolin-1 phosphorylation. Instead, the 
phosphorylation of caveolin-1 was found to be increased in the desmosterol cells, perhaps 
in order to preserve caveolar endocytosis. Taking all this into account, a likely explanation 
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for  the  decrease  in  caveolar  uptake  is  a  reduced  affinity  of  BODIPY-lactocylceramide  and  
cross-linked integrins for caveolae. This would be in line with the previous observation that 
activated insulin receptors had a reduced affinity for membrane rafts in cells containing 
desmosterol (Vainio et al., 2006). 
 
2. Using BODIPY-cholesterol to study intracellular sterol transport  
2.1 Characterizing BODIPY-cholesterol as a tool for studying cholesterol transport 
The  second  part  of  this  study  aimed  to  resolve  whether  the  fluorescent  sterol  probe  
BODIPY-cholesterol  can  be  used  as  a  tool  to  study  cholesterol  transport  from  the  plasma  
membrane to the ER and lipid droplets. Three transport assays based on live cell microscopy 
were developed. For all experiments HeLa cells were used that were incubated overnight 
with 0.35 to 0.5 mM oleate. The oleate load increased the cellular triacylglyceride content 
from ?5 to ?30 µg/mg cellular protein, which facilitated lipid droplet visualization.  
 
 
Figure 10. BODIPY-cholesterol transport from the plasma membrane to lipid droplets. (A) 
Hela cells were prelabeled with BODIPY-C12 to stain lipid droplets. The plasma membrane 
was pulse labeled with BODIPY-cholesterol (BODIPY-chol). Shown are confocal images at 
different chase times. Scale bar: 15 µm. (B) Pearson’s correlation of BODIPY-cholesterol and 
BODIPY-C12 as a function of time. Combined data from three independent experiments. Gray 
areas indicate time windows used for quantification in later experiments. 
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Transport assay I: BODIPY-cholesterol transport from plasma membrane to lipid droplets 
To study sterol transport from the plasma membrane to lipid droplets a live cell microscopy 
pulse  chase  assay  was  developed.  Lipid  droplets  were  visualized  by  labeling  with  the  
fluorescent fatty acid analog BODIPY-C12. This label is preferentially incorporated in di- and 
triacylglycerides at the time points analyzed (Kasurinen, 1992). Next, the plasma membrane 
was pulse labeled with trace amounts of BODIPY-cholesterol. The cells were imaged 
continuously for up to 3 h by confocal microscopy while keeping the temperature at 37 °C. 
Within the first 10 min after labeling some of the BODIPY-cholesterol started to localize to 
lipid droplets (Figure 10A). The transfer of BODIPY-cholesterol to lipid droplets proceeded 
for about 1 h, at which time a steady state appeared to be reached. The kinetics of transport 
was quantified by determining the time-dependent colocalization between BODIPY-
cholesterol and BODIPY-C12. The colocalization, as expressed by the Pearson’s correlation 
coefficient, was plotted as a function of time (Figure 10B). This curve revealed that BODIPY-
cholesterol moved from the plasma membrane to lipid droplets with a halftime (t½) of 
?30 min. 
  
Transport assay II: BODIPY-cholesterol transport from plasma membrane to ER 
An  assay  identical  to  “transport assay I” was used except that an ER-tracker was utilized 
instead  of  the  lipid  droplet  marker  (III, Figure 6A). The plot of the Pearson’s correlation 
between BODIPY-cholesterol and the ER-tracker as a function of time revealed transport t½ 
of ?30  min  (III,  Figure  6B),  which  is  similar  to  the  kinetics  found  for  plasma  membrane  to  
lipid droplet transport of BODIPY-cholesterol.  
 
Transport assay III: FRAP of BODIPY-cholesterol in lipid droplets 
Cells were labeled with BODIPY-cholesterol, which was allowed to equilibrate during a 3 h 
incubation period. Next, the BODIPY-cholesterol in a cluster of immobile lipid droplets was 
photobleached (III, Figure 5). The fluorescence recovery within those lipid droplets was 
measured as a function of time. The t½ of recovery was found to be ?1 min.  
 
Biochemical analysis of [3H]cholesterol and BODIPY-cholesterol transport 
Transport of [3H]cholesterol and BODIPY-cholesterol from the plasma membrane to lipid 
droplets was analyzed with a biochemical pulse chase assay. The plasma membrane was 
pulse labeled with [3H]cholesterol from a BSA complex or with BODIPY-cholesterol from a 
??CD complex. Next, the lipid droplets were isolated by sucrose density gradient 
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fractionation after different chase times. The purified lipid droplet fraction was, as 
expected, enriched in triacylglycerides and adipocyte differentiation-related protein (ADRP) 
(Martin and Parton, 2005). Furthermore, the lipid droplet fraction contained no or little 
plasma membrane and ER contamination, as shown by Na+/K+-ATPase and calnexin Western 
blotting (III, Figure 1C). The time dependent lipid droplet association of unesterified 
[3H]cholesterol and BODIPY-cholesterol was determined, indicating transport halftimes of 
?45 min and ?30 min, respectively (III, Figure 1D, S2). It is of note that, at steady state, the 
BODIPY-cholesterol lipid droplet content was ?4 times higher compared to unesterified 
natural cholesterol.   
 
Effects of pharmacological treatments on BODIPY-cholesterol transport. 
Next, the effects of several pharmacological treatments on BODIPY-cholesterol transport 
from the plasma membrane to lipid droplets were investigated (III,  Figure  2).  In  order  to  
make the assay time-efficient, confocal images were acquired only at two chase times: 
15-25 min after labeling, at which time there is a net transport of BODIPY-cholesterol to lipid 
droplets, and 180 min after labeling, when a steady state is reached (Figure 10B). The 
transport kinetics of BODIPY-cholesterol was not altered by ATP depletion as judged by 
unaltered colocalization between the sterol probe and the lipid droplet marker after both 
15-25 min and 180 min chase. On the other hand, hydrolyzing the sphingomyelin on the 
plasma membrane using sphingomyelinase increased the colocalization after 15-25 min 
chase but not at steady state. This indicates that sphingomyelinase treatment increases 
BODIPY-cholesterol  transport  to  lipid  droplets  but  has  no  effect  on  the  total  amount  of  
sterol transported. Brefeldin A, on the other hand, did not affect transport at either time 
point.  
 
BODIPY-cholesterol esterification 
The degree of BODIPY-cholesterol esterification was analyzed by TLC and compared to that 
of [3H]cholesterol. After a 3 h chase, 7% of the [3H]cholesterol was esterified (III, Figure 1D) 
whereas no BODIPY-cholesterol esters could be detected. In order to determine whether 
BODIPY-cholesterol can get esterified in HeLa cells, the cells were labeled for 24 h in 
medium containing 1 µM BODIPY-cholesterol. This procedure results in 10 times more 
BODIPY-cholesterol moving into the cells compared to the M?CD labeling protocol that was 
used in all other experiments. In order to stimulate the formation of cholesteryl esters, the 
cells were loaded with cholesterol from a M?CD/cholesterol complex (6:1; 2 mM M?CD). 
Under these conditions, 2.5% of the BODIPY-cholesterol got esterified. This was 20 times 
lower compared to the fraction of esterified cholesterol in the same cells (Figure 11).  
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Figure 11. Esterification of BODIPY-cholesterol. HeLa cells were labeled overnight with 1 µM 
BODIPY-cholesterol  (BODIPY-C)  in  the presence of  a M?CD/cholesterol  complex (6:1;  2  mM 
??CD). Lipids were extracted and analyzed by HPTLC. BODIPY-cholesterol and BODIPY-
cholesterol esters (BODIPY-CE) were visualized with a fluorescent plate reader.  
 
2.2 ORP dependent transport of cholesterol to the ER and lipid droplets 
Screening of ORPs in BODIPY-cholesterol transport from plasma membrane to lipid droplets 
The  BODIPY-cholesterol  plasma  membrane  to  lipid  droplet  transport  assay  was  used  to  
analyze the effect of ORP overexpression on sterol traffic. HeLa cells were transiently 
transfected with cDNAs of all human ORP splice variants containing an N-terminal Xpress 
tag. Xpress-ORP protein levels were analyzed by Western blotting showing that all were 
expressed albeit at varying levels (III, Figure 3B). In order to identify the ORP overexpressing 
cells by fluorescence microscopy, the ORP constructs were co-overexpressed with a plasmid 
coding for the fluorescent protein HcRed. As judged by ?-Xpress staining, ?90% of the cells 
expressing HcRed also expressed the Xpress-ORP (III, Figure S1). Confocal images were taken 
at 15-25 min after BODIPY-cholesterol labeling of fields in which more than half of the cells 
were expressing HcRed. Overexpression of several ORPs increased the colocalization 
between BODIPY-cholesterol and lipid droplets (III,  Figure  3C;  Figure  12).  Out  of  these,  
ORP1S and ORP2 gave the largest increase. Because overexpression of ORP1S and ORP2 did 
not alter the colocalization at steady state (180 min chase) (III, Figure 3C; Figure 12), these 
results  suggest  that  ORP1S  and  ORP2  can  increase  the  plasma  membrane  to  lipid  droplet  
transport kinetics of BODIPY-cholesterol. The protein levels of overexpressed ORP1S and 
ORP2  were  roughly  similar  to  those  of  OSBP,  ORP1L,  ORP3,  ORP5,  ORP7  and  ORP9S.  
Therefore, out of these ORPs, ORP1S and ORP2 appear to be most efficient in enhancing 
BODIPY-cholesterol transport to lipid droplets. 
63  
 
Figure 12. ORP2 overexpression increases BODIPY-cholesterol transport to lipid droplets. 
HeLa cells coexpressing ORP2 and HcRed were prelabeled with BODIPY-C12 and pulse labeled 
with BODIPY-cholesterol (BODIPY-chol). Shown are confocal images after 15 min and 180 
min chase. Scale bar: 15 µm. 
 
ORP2 mediated transport of natural sterols  
It  was  next  clarified  whether  the  ORP2  mediated  sterol  transport  also  applies  to  natural  
sterols. The effect of ORP2 overexpression on the plasma membrane to lipid droplet 
transport of dehydroergosterol was analyzed by epifluorescent microscopy.  In this 
experiment, Huh7 cells were used because their large lipid droplets facilitate the 
visualization of dehydroergosterol in lipid droplets. As was shown for BODIPY-cholesterol, 
dehydroergosterol transport from the plasma membrane to lipid droplets was stimulated by 
ORP2 overexpression (III, Figure S5).  
Next, the effect of ORP2 overexpression on the esterification of plasma membrane derived 
[3H]cholesterol was analyzed. Because cholesterol is esterified by ACAT in the ER, this assay 
indirectly measures cholesterol transport from the plasma membrane to the ER. ORP2 
overexpression significantly increased the fraction of [3H]cholesterol esters after a 30 min 
chase time (III, Figure 4D). ORP2 overexpression did not affect the ability of ACAT to esterify 
sterols, as determined by an in vitro activity assay. Therefore, it is likely that the higher 
esterification resulted from increased cholesterol transport to the ER. This result is in 
agreement with findings from the BODIPY-cholesterol plasma membrane to ER transport 
assay that showed a similar ORP2 dependency (III, Figure 6C,D). Interestingly, the FRAP of 
BODIPY-cholesterol in lipid droplets was shown to be unaffected by ORP2 overexpression 
(III, Figure 5B). 
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Physiological role for ORP1 and ORP2 in sterol transport 
We determined the endogenous levels of ORP1S and ORP2 in HeLa cells by Western blotting 
using purified recombinant proteins as calibrators. Both proteins were found to be present 
at around one million copies per cell (our unpublished results). Next, the effect of 
simultaneous knockdown of ORP1 and ORP2 on BODIPY-cholesterol transport from the 
plasma membrane to lipid droplets was measured. On a side note, because the ORP1S splice 
variant cannot be selectively silenced, both ORP1L and ORP1S were downregulated. 
Knockdown resulted in a moderate but significant reduction of sterol transport kinetics 
(III, Figure 4B). Of note, single knockdown of either ORP1 or ORP2 had no effect on sterol 
transport (our unpublished observations).  In order to analyze whether ORP1 and ORP2 
double knockdown effects the transport of natural sterols, the esterification of plasma 
membrane derived [3H]cholesterol was analyzed. Knockdown decreased the esterification of 
[3H]cholesterol without altering ACAT activity, suggesting a reduction of cholesterol 
transport from the plasma membrane to the ER (III, Figure 4C).  
 
ORP dependent in vitro sterol transfer 
To assess more directly whether ORP1S and ORP2 can function as cholesterol transporters, 
cholesterol transfer was studied in vitro. Recombinant Glutathione-S-transferase (GST) 
fusion proteins of ORP1S, ORP2, and the MLN64 START domain were produced in E. coli and 
purified using Glutathione-Sepharose. The ability of these proteins to stimulate 
[3H]cholesterol transfer from large unilamellar vesicles to a 50-fold molar excess of acceptor 
vesicles was analyzed. ORP1S significantly increased sterol transfer to acceptor vesicles 
(III,  Figure  4E).  A  similar  tendency  was  found  for  ORP2.  These  results  suggest  that  ORP1S  
and ORP2 function as sterol transporters. However, the transfer activity of both ORPs was 
substantially lower than that of MLN64 START domain which was used as a positive control.  
 
Role of conserved domains in sterol transport 
Next, the importance of two conserved domains present in ORP2, the ORD and FFAT motif 
was analyzed for BODIPY-cholesterol transport from the plasma membrane to lipid droplets 
(III, Figure 4F). Overexpression of an ORP2 I249W mutant (ORP2mORD), which is defective 
in binding sterols, was unable to stimulate BODIPY-cholesterol transport. On the other hand, 
overexpression of an ORP2 mutant with a defective FFAT-motif (ORP2mFFAT) increased 
BODIPY-cholesterol transport to lipid droplets to the same extent as wild-type ORP2. 
Western blot analysis indicated that the lack of transport activity of the ORD mutant could 
not be explained by reduced expression levels (III,  Figure  4G).   Therefore,  these  results  
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indicate that a functional ORD, capable of cholesterol binding, is necessary for ORP2 
mediated sterol transfer activity. 
 
2.3 VAP proteins are involved in cholesterol transport by stabilizing ORPs 
VAP knockdown decreases ORP2 levels and sterol transport 
The effect of VAP-A and/or VAP-B knockdown on BODIPY-cholesterol transport from the 
plasma membrane to lipid droplets was investigated. Knockdown of either VAP-A or VAP-B 
alone did not affect this transport (Jansen and Ikonen, unpublished observations), but 
simultaneous knockdown of both proteins resulted in slower BODIPY-cholesterol trafficking 
from the plasma membrane to lipid droplets, as suggested by reduced colocalization of 
BODIPY-cholesterol and lipid droplets at 15-25 min of chase (III, Figure 7A).  
To  assess  whether  ORP2  can  facilitate  sterol  transfer  in  the  absence  of  VAPs,  ORP2  was  
overexpressed in control and VAP-A/B knockdown cells and the delivery of BODIPY-
cholesterol from the plasma membrane to lipid droplets was analyzed. ORP2 overexpression 
increased BODIPY-cholesterol transport kinetics in a similar extent in both control and VAP-
A/B  knockdown  cells  (III, Figure 7A). This demonstrates that ORP2 can facilitate sterol 
transport independently of VAPs.  
 
VAPs stabilize endogenous ORPs by interacting with their FFAT motif 
To investigate whether ORPs are involved in the effect of VAP knockdown on sterol 
transport, ORP2 levels were analyzed by Western blotting. A significant reduction in the 
amount  of  ORP2  was  observed  in  the  VAP-A/B  silenced  cells  (III, Figure 7B). Conversely, 
VAP-A overexpression resulted in increased levels of the endogenous ORP2 protein 
(III,  Figure  7D).  By  using  [35S]methionine pulse-chase experiments followed by 
immunoprecipitation, it was found that ORP2 degrades more rapidly in VAP-A/B silenced 
cells (III, Figure 7C), suggesting the need of VAPs for ORP2 stability.  
To study whether the FFAT motif is important for VAP dependent ORP2 stability, the effect 
of VAP-A/B knockdown on the level of overexpressed ORP2mFFAT was analyzed 
(III, Figure 7E). Overexpressed ORP2 wild-type was downregulated whereas the ORP2mFATT 
was not, indicating the importance of the FFAT domain for ORP stability. Consistently with 
this, endogenous levels of the FFAT motif containing ORPs, ORP1L and ORP3, were 
downregulated by VAP-A/B silencing, whereas ORP1S and ORP11 that lack a FFAT motif 
were  not  (III, Figure 7F). Still, not all FFAT motif containing ORPs were downregulated by 
VAP-A/B silencing, as indicated by ORP4 and ORP9. 
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2.4 Discussion 
Characterizing BODIPY-cholesterol as a tool for studying cholesterol transport 
BODIPY-cholesterol was characterized as a tool for studying cholesterol transport between 
the plasma membrane, the ER and lipid droplets by comparing the transport kinetics of 
BODIPY-cholesterol with the kinetics of natural sterols. BODIPY-cholesterol moved from the 
plasma  membrane  to  lipid  droplets  with  a  t½ of ?30  min,  which  is  roughly  similar  to  the  
kinetics observed for unesterified [3H]cholesterol. These results are also in agreement with a 
previous study that analyzed the transport kinetics of dehydroergosterol for the same route 
(Wustner et al., 2005). The transport of BODIPY-cholesterol from the plasma membrane to 
the ER also occurred with a t½ of ?30 min, which is very similar to the kinetics found for ER 
to plasma membrane transport as determined by the time dependent oxidation of newly 
synthesized cholesterol (Lange et al., 1991). Furthermore, the recovery of BODIPY-
cholesterol fluorescence in lipid droplets occurred with a t½ ?1  min,  as  also  observed  for  
dehydroergosterol (t½: ?1.5 min) (Wustner et al., 2005). BODIPY-cholesterol was further 
characterized by analyzing the effects of pharmacological treatments on BODIPY-cholesterol 
transport. BODIPY-cholesterol traffic to lipid droplets was unaffected by ATP depletion, as 
was  shown  previously  for  dehydroergosterol  (Wustner  et  al.,  2005).  Furthermore,  the  
present observations that plasma membrane to lipid droplet transport of BODIPY-
cholesterol is affected by SMase but insensitive to BFA treatment, share similarities with 
cholesterol traffic between the plasma membrane and the ER, which is affected by 
sphingomyelinase  (Okwu  et  al.,  1994)  but  mostly  insensitive  to  brefeldin  A  (Heino  et  al.,  
2000). Together, these results show that BODIPY-cholesterol resembles natural cholesterol 
regarding transport from the plasma membrane to the ER and lipid droplets.  
Considering the observation that an additional double bond in the sterol side chain has 
pronounced effects on ordered membrane domains, it is remarkable that the addition of the 
bulky BODIPY-group does not radically change the behavior of the sterol. This can partly be 
explained by the low concentration of BODIPY-cholesterol within the labeled cells. The 
presence  of  trace  amounts  of  BODIPY-cholesterol  probably  has  no  major  effect  on  
membrane properties. Furthermore, present results show that BODIPY-cholesterol does not 
mimic all cell biological behavior of natural cholesterol. At steady state the cellular fraction 
of BODIPY-cholesterol in lipid droplets was around four times higher compared to that of 
natural cholesterol. This might be explained by the affinity of the BODIPY-group for lipid 
droplets (Listenberger and Brown, 2007). Furthermore, the rate of BODIPY-cholesterol 
esterification was found to be significantly lower compared to that of natural cholesterol. In 
most cell types, lipid droplet sterols are predominantly present in esterified form. 
Therefore, BODIPY-cholesterol transport kinetics to lipid droplets only mimics the transfer of 
free cholesterol, not of cholesterol esters. Nevertheless, the study of free sterol transport to 
lipid droplets is informative since lipid droplets do contain small amounts of unesterified 
67  
cholesterol. Notably, in the lipid droplets of human adipocytes, 90% of the cholesterol is 
present in unesterified form (Schreibman and Dell, 1975). 
 
ORP dependent transport of cholesterol to the ER and lipid droplets 
In the overexpression screen, ORP1S and ORP2 were found to be most efficient in 
facilitating sterol transport from the plasma membrane to lipid droplets. Interestingly, these 
two ORPs are part of the same subfamily based on sequence similarity. Another structural 
feature that ORP1S and ORP2 have in common is the absence of a PH domain (Raychaudhuri 
et al., 2006). This lack is relatively rare in mammalian ORPs since twelve of the sixteen splice 
variants tested in our screen do contain a PH domain.  In yeast studies, it has been shown 
that out of the three ORPs most effective in mediating sterol transport, two are missing a PH 
domain. Together, these findings show that a PH domain is not necessary for ORP mediated 
sterol transport. Furthermore, they suggest that absence of this domain might improve its 
efficiency in mediating sterol transport. Possibly, interactions between PI containing 
membranes and the PH domain hinder the sterol transfer activity of ORPs. 
To  obtain  more  insight  into  the  transport  route(s)  of  sterols  moving  from  the  plasma  
membrane to lipid droplets, the recovery of BODIPY-cholesterol was analyzed in lipid 
droplets after photobleaching. The t½ of  BODIPY-cholesterol  FRAP  was  very  rapid,  ?1 min, 
and  unaffected  by  ORP2  overexpression.  This  implies  that  the  majority  of  BODIPY-
cholesterol moving to lipid droplets do not come directly from the plasma membrane, since 
the  t½ for plasma membrane to lipid droplet transport is ?30 min. There are several 
arguments that suggest that most BODIPY-cholesterol moving from the plasma membrane 
to  lipid  droplets  transfers  through  the  ER  (Figure  13):   (1)  plasma  membrane  to  ER  and  
plasma  membrane  to  lipid  droplet  transport  are  stimulated  in  a  similar  manner  by  ORP2  
overexpression, (2) the kinetics of sterol transport from plasma membrane to ER (?30 min) 
+ lipid droplet FRAP (?1 min) is similar to the kinetics of plasma membrane to lipid droplet 
transport (?30 min), (3) The ER has been shown to be in close proximity to both the plasma 
membrane and lipid droplets, (4) cholesterol esters are synthesized in the ER before 
deposition in lipid droplets. Although it appears likely that sterols moving to lipid droplets 
come from the ER, the present results do not exclude transport routes involving other 
cellular compartments. 
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Figure 13. Model of cholesterol transport from the plasma membrane to lipid droplets 
based on the results of this study. Cholesterol transport is indicated by the straight arrows. 
The bended arrow indicates the stabilization of ORP’s (blue) by VAP-A/B (green). The 
rationale behind this model is discussed in the text.  
 
In this study, results from the ORP overexpression screen using BODIPY-cholesterol were 
validated  with  assays  using  dehydroergosterol  and  [3H]cholesterol. These results indicate 
that  the  effects  of  ORPs  on  sterol  transport  are  similar  for  the  three  tested  sterols.  This  
implies that the bulky BODIPY group is not hindering binding of BODIPY-cholesterol within 
the hydrophobic cavity of the ORP proteins. The crystal structure of the yeast ORP Osh4, in 
complex with cholesterol, indicates that hydroxyl side of cholesterol is buried deep inside 
the hydrophobic Osh4 tunnel whereas the side chain region is covered by a flexible lid (Im et 
al.,  2005).  The  same  study  shows  that  also  25-HC  can  be  complexed  with  Osh4.  The  25-
hydroxyl group of 25-HC was found to bind ordered water molecules close to the flexible lid. 
The presence of water molecules inside that region of the binding pocket indicates that 
there is extra space within the part of the tunnel that is expected to harbor the BODIPY-
group of BODIPY-cholesterol. This additional space might explain how mammalian ORPs can 
bind BODIPY-cholesterol and mediate its transfer. 
The finding that ORP1S and ORP2 are capable of transferring cholesterol in vitro suggests 
that they might directly transfer cholesterol in cells. It was approximated that ?40,000 
cholesterol molecules move every second from the plasma membrane to the ER. This value 
was calculated with the assumptions that 2% of cellular cholesterol is in the ER (Lange and 
Steck, 1997), one HeLa cell contains 5 billion cholesterol molecules, the t½ of cholesterol 
transport to the ER is 1800 s and that transport occurs by first-order kinetics: 
 0.02 · 5 · 109 · ??(?)
????
=  ?40,000. Taking  into  account  that  ORP1S  and  ORP2  are  each  
present at 1 million copies per cell, this means that these ORPs are present at an abundance 
that would allow them to significantly contribute to the plasma membrane to ER cholesterol 
transport  by  acting  as  sterol  carriers.  Nevertheless,  these  results  do  not  allow  us  to  draw  
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conclusions regarding the mechanism by which ORPs facilitate sterol transport from the 
plasma membrane to the ER.   
Even though double knockdown of ORP1 and ORP2 reduced sterol transport from the 
plasma membrane to the ER and lipid droplets, the decrease was only moderate. This mild 
affect could be explained by a functional redundancy within the human ORP family 
regarding sterol transport. Such an explanation appears likely since the present ORP 
overexpression screen indicated that other ORPs can also stimulate sterol transport, albeit 
less efficiently. A functional redundancy in the human ORP family would also be in line with 
results from yeast, which suggest that all Osh proteins are involved in sterol transport from 
the plasma membrane to the ER (Raychaudhuri et al., 2006). It is also possible that there are 
ORP independent sterol transport mechanisms between the plasma membrane and the ER. 
Such mechanisms might be mediated by other LTPs, such as SCP-2 or members of the START 
family (Puglielli et al., 1995; Soccio et al., 2005).  
 
VAP proteins are involved in cholesterol transport by stabilizing ORPs 
VAPs have been implicated in lipid transport (Kawano et al., 2006; Peretti et al., 2008) and 
interact with the FFAT domain present in several ORPs. In the present study VAP-A/B double 
knockdown reduces BODIPY-cholesterol transport from plasma membrane to lipid droplets. 
VAPs  stabilize  ORP2  protein  levels  in  a  FFAT  domain  dependent  manner  and  the  protein  
levels of several FFAT domain containing ORPs were downregulated by VAP-A/B silencing. 
Therefore, it seems likely that the reduction in sterol transport is caused by the effect of 
VAPs on the stability of FFAT domain containing ORPs. It should be noted that VAP 
interacting proteins include a number of lipid binding/transport proteins, such as CERT and 
Nir1-3 (Loewen et al., 2003). Therefore, silencing of VAPs might affect sterol transport by 
ORP unrelated mechanisms. Yet another cause for the decrease in sterol transport upon 
VAP-A/B knockdown could be a requirement of VAPs for the sterol transfer activity of ORPs. 
This would be in line with a study that suggests that VAP dependent targeting to the ER is 
important for the activity of the FFAT domain containing CERT (Kawano et al., 2006). 
However, the present results provide evidence that interaction between the ORP FFAT 
domain and VAPs is not directly involved in the sterol transport function of ORPs: (1) ORP2 
overexpression stimulated sterol transport in the absence of VAPs, (2) overexpression of 
ORP2 with a defective FFAT motif induced sterol transport to a similar extent compared to 
overexpression of wild-type ORP2, (3) overexpression of ORP1S, which does not contain 
a FFAT motif, gave the highest increase in sterol transport out of all screened ORPs. Studies 
by  other  laboratories  also  suggest  that  the  FFAT-VAP  interaction  is  not  relevant  for  ORP  
mediated sterol transport. In yeast, the ORPs that were found to be most important for 
sterol transfer from the plasma membrane to the ER did not contain a FFAT motif 
(Raychaudhuri et al., 2006). It has also been shown that ORPs in yeast can use their ORD to 
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target the ER, illustrating that a FFAT motif is not necessary for localization to this organelle 
(Schulz et al., 2009). However, despite this evidence, it is possible that the ORP-VAP 
interactions may under physiologic conditions be functionally important for sterol transport; 
upon overexpression, activity of CERT was shown to be independent of VAPs, whereas at 
lower expression levels, VAP interaction was shown to be important (Kawano et al., 2006).  
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CONCLUSIONS 
Desmosterol as a tool to study ordered membrane domains 
1. Desmosterol cannot functionally replace cholesterol in ordered membrane domains 
2. Exchanging cellular cholesterol for desmosterol provides a selective tool for perturbing ordered 
membrane domains 
3. Cholesterol is important for the stability and structural homogeneity of caveolae 
 
Using BODIPY-cholesterol to study intracellular cholesterol transport 
1. BODIPY-cholesterol behaves similarly to natural cholesterol regarding transport between the 
plasma membrane, the ER and lipid droplets 
2. ORP1S and ORP2 facilitate cholesterol transport from the plasma membrane to the ER 
3. ORP1S and ORP2 can transfer cholesterol in vitro 
4. VAP proteins are involved in cholesterol transport from the plasma membrane to the ER by 
stabilizing ORPs 
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PERSPECTIVES 
In  this  work,  cholesterol  analogs  were  used  to  analyze  cell  biological  functions  of  
cholesterol. Sterol substitution has in the past been used to analyze the role of cholesterol 
for biological processes including endocytosis (Heese-Peck et al., 2002), cell growth 
(Rujanavech  and  Silbert,  1986),  lipid  adaptation  (Low  et  al.,  1985)  and  receptor  binding  
affinity (Klein et al., 1995). In the present study, this procedure was used for the first time to 
analyze the importance of cholesterol for ordered membrane domains in cells. The most 
common procedure to disrupt ordered membranes is by cholesterol removal or 
sequestration. These techniques lack selectivity as they affect general membrane properties 
outside ordered domains. Exchanging cholesterol for desmosterol was found to perturb 
ordered membrane domains without significantly altering other membrane functions as 
indicated by unchanged cell growth/viability, subcellular sterol distribution, Golgi integrity, 
secretory pathway, phospholipid composition and membrane fluidity. Furthermore, the 
sterol substitution perturbed caveolae without totally abolishing them. This can be an 
advantage since it allows the analysis of the role of cholesterol for caveolar structure. On 
the other hand, the lack of total disruption can also be a drawback, since the effect of the 
sterol substitution might be small or even absent. For instance, even though the sterol 
substitution altered the caveolar structure, the endocytic function of caveolae was only 
moderately affected. For this reason it would be interesting to screen the effects of other 
cholesterol precursors on ordered membrane domains in cells.  It is likely that inhibition of 
an enzyme more upstream of cholesterol biosynthesis would have more pronounced effects 
on ordered membrane domains in cells. However, cholesterol precursors more upstream 
are also more likely to affect cellular functions unrelated to ordered membrane domains. In 
the end, it would be probably best to use a combination of sterol manipulations, ranging in 
severity, to analyze ordered membrane domains in cells in a prudent manner. 
Cholesterol  transport  from  the  plasma  membrane  to  the  ER  and  lipid  droplets  is  an  
important mechanism by which cells regulate their membrane cholesterol content. By 
comparing transport kinetics and the effect of drug treatments, BODIPY-cholesterol 
resembles cholesterol regarding its transport from the plasma membrane to the ER and lipid 
droplets. By using BODIPY-cholesterol, this study uncovered a role for ORPs and VAPs in the 
transport of sterols from the plasma membrane to the ER in mammalian cells.  Even though 
our results are in line with a sterol transport function of ORPs, they do not exclude other 
mechanisms of  transfer.  In  order to address this  question,  yeast  would be a better  model  
since it allows for multiple knockouts. One could screen whether overexpression of 
mammalian proteins, capable of in vitro sterol transfer (e.g. the MLN64 START domain), can 
restore viability in the yeast strain lacking all Osh proteins. In case a sterol transporter could 
substitute  for  ORPs  in  yeast  this  would  strongly  suggest  that  ORPs  function  as  sterol  
transporters in cells. Another unresolved issue is the importance of ORP mediated sterol 
transport from the plasma membrane to the ER in mammalian cells. Even though ORP1 and 
ORP2 were efficient in mediating sterol transport upon overexpression, their knockdown 
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gave  only  a  moderate  reduction  in  sterol  transfer.  This  issue  could  be  addressed  by  
disrupting the function all mammalian ORPs simultaneously.  The development of 
pharmacological ORP inhibitors would be helpful for this purpose. 
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